Disease:
Asthma

The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.

The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page.

Gene ? Variant?
(147)
Alternate Names ? Chemicals ? Alleles ?
(+ chr strand)
Function ? Amino Acid?
Translation
No VIP available No VIP available No VIP available CYP2C19 *1 N/A N/A N/A
No VIP available No VIP available No VIP available CYP2C19 *2 N/A N/A N/A
No VIP available No VIP available No VIP available CYP2C19 *3 N/A N/A N/A
No VIP available No VIP available No VIP available CYP2C19 *8 N/A N/A N/A
No VIP available No VIP available No VIP available CYP2C19 *9 N/A N/A N/A
No VIP available CA VA HLA-DPB1 *03:01:01 N/A N/A N/A
No VIP available CA No VIP available HLA-DPB1 *04:01:01:01 N/A N/A N/A
No VIP available No VIP available No VIP available UGT1A1 *1 N/A N/A N/A
No VIP available No VIP available No VIP available UGT1A1 *28 N/A N/A N/A
No VIP available No VIP available No VIP available UGT1A3 *2 N/A N/A N/A
No VIP available CA VA
rs1029489 NC_000016.10:g.27364896A>G, NC_000016.9:g.27376217A>G, NG_012086.1:g.55967A>G, NM_000418.3:c.*1066A>G, NM_001257406.1:c.*1066A>G, NM_001257407.1:c.*1066A>G, NM_001257997.1:c.*1066A>G, XM_005255305.1:c.*1066A>G, XM_005255306.1:c.*1066A>G, XM_005255307.1:c.*1066A>G, XM_005255308.1:c.*1066A>G, XM_005255308.2:c.*1066A>G, XM_006721043.1:c.*1066A>G, XM_011545825.1:c.*1066A>G, XM_011545826.1:c.*1066A>G, XM_011545827.1:c.*1066A>G, XM_011545828.1:c.*1066A>G, XM_011545829.1:c.*1066A>G, XM_011545830.1:c.*1066A>G, XM_011545831.1:c.*1066A>G, XM_011545832.1:c.*1066A>G, XM_011545833.1:c.*1066A>G, XM_011545834.1:c.*1066A>G, rs386511926, rs58796356
A > G
SNP
No VIP available No Clinical Annotations available VA
rs10306135 NC_000009.11:g.125137695A>T, NC_000009.12:g.122375416A>T, NG_032900.1:g.9467A>T, NM_000962.2:c.95-2483A>T, NM_000962.3:c.95-2483A>T, NM_001271164.1:c.95-2483A>T, NM_001271165.1:c.-262A>T, NM_001271166.1:c.-233-2483A>T, NM_001271367.1:c.-204-2512A>T, NM_001271368.1:c.20-2483A>T, NM_080591.2:c.95-2483A>T, XM_005252104.1:c.20-2483A>T, XM_005252105.1:c.20-2483A>T, XM_005252105.2:c.20-2483A>T, XM_005252106.1:c.-233-2483A>T, XM_011518875.1:c.20-2483A>T, XM_011518876.1:c.-262A>T
A > T
SNP
No VIP available CA VA
rs1042136 NC_000006.11:g.33048628A=, NC_000006.11:g.33048628A>C, NC_000006.12:g.33080851A=, NC_000006.12:g.33080851A>C, NG_033241.1:g.4928T=, NG_033241.1:g.4928T>G, NG_033242.1:g.9926A=, NG_033242.1:g.9926A>C, NM_001242524.1:c.-271G>T, NM_001242524.1:c.-271T>G, NM_001242525.1:c.-195G>T, NM_001242525.1:c.-195T>G, NM_002121.5:c.280A=, NM_002121.5:c.280A>C, NP_002112.3:p.Ile94=, NP_002112.3:p.Ile94Leu, NT_113891.2:g.4492807C=, NT_113891.2:g.4492807C>A, NT_113891.3:g.4492701C=, NT_113891.3:g.4492701C>A, NT_167244.1:g.4335435A=, NT_167244.1:g.4335435A>C, NT_167244.2:g.4385519A=, NT_167244.2:g.4385519A>C, NT_167245.1:g.4329967A=, NT_167245.1:g.4329967A>C, NT_167245.2:g.4324382A=, NT_167245.2:g.4324382A>C, NT_167246.1:g.4506174A=, NT_167246.1:g.4506174A>C, NT_167246.2:g.4500554A=, NT_167246.2:g.4500554A>C, NT_167247.1:g.4385489A=, NT_167247.1:g.4385489A>C, NT_167247.2:g.4379904A=, NT_167247.2:g.4379904A>C, NT_167248.1:g.4281085A=, NT_167248.1:g.4281085A>C, NT_167248.2:g.4275489A=, NT_167248.2:g.4275489A>C, NT_167249.1:g.4529132A=, NT_167249.1:g.4529132A>C, NT_167249.2:g.4529834A=, NT_167249.2:g.4529834A>C, XM_006715078.2:c.-33A=, XM_006715078.2:c.-33A>C, XM_006725040.2:c.-33A=, XM_006725040.2:c.-33A>C, XM_006725699.2:c.-33A=, XM_006725699.2:c.-33A>C, XM_006725817.2:c.-33A=, XM_006725817.2:c.-33A>C, XM_006725908.2:c.-33A=, XM_006725908.2:c.-33A>C, XM_006725998.2:c.-33A=, XM_006725998.2:c.-33A>C, XM_006726088.2:c.-33A=, XM_006726088.2:c.-33A>C, rs111297925, rs111936448, rs115274041, rs116864197, rs17221122, rs3173293
A > C
SNP
I94L
No VIP available CA VA
rs1042151 NC_000006.11:g.33048661A=, NC_000006.11:g.33048661A>G, NC_000006.12:g.33080884A=, NC_000006.12:g.33080884A>G, NG_033241.1:g.4895T=, NG_033241.1:g.4895T>C, NG_033242.1:g.9959A=, NG_033242.1:g.9959A>G, NM_001242524.1:c.-304C>T, NM_001242524.1:c.-304T>C, NM_001242525.1:c.-228C>T, NM_001242525.1:c.-228T>C, NM_002121.5:c.313A=, NM_002121.5:c.313A>G, NP_002112.3:p.Met105=, NP_002112.3:p.Met105Val, NT_113891.2:g.4492840G=, NT_113891.2:g.4492840G>A, NT_113891.3:g.4492734G=, NT_113891.3:g.4492734G>A, NT_167244.1:g.4335468A=, NT_167244.1:g.4335468A>G, NT_167244.2:g.4385552A=, NT_167244.2:g.4385552A>G, NT_167245.1:g.4330000A=, NT_167245.1:g.4330000A>G, NT_167245.2:g.4324415A=, NT_167245.2:g.4324415A>G, NT_167246.1:g.4506207A=, NT_167246.1:g.4506207A>G, NT_167246.2:g.4500587A=, NT_167246.2:g.4500587A>G, NT_167247.1:g.4385522A=, NT_167247.1:g.4385522A>G, NT_167247.2:g.4379937A=, NT_167247.2:g.4379937A>G, NT_167248.1:g.4281118A=, NT_167248.1:g.4281118A>G, NT_167248.2:g.4275522A=, NT_167248.2:g.4275522A>G, NT_167249.1:g.4529165A=, NT_167249.1:g.4529165A>G, NT_167249.2:g.4529867A=, NT_167249.2:g.4529867A>G, XM_006715078.2:c.1A=, XM_006715078.2:c.1A>G, XM_006725040.2:c.1A=, XM_006725040.2:c.1A>G, XM_006725699.2:c.1A=, XM_006725699.2:c.1A>G, XM_006725817.2:c.1A=, XM_006725817.2:c.1A>G, XM_006725908.2:c.1A=, XM_006725908.2:c.1A>G, XM_006725998.2:c.1A=, XM_006725998.2:c.1A>G, XM_006726088.2:c.1A=, XM_006726088.2:c.1A>G, XP_006715141.1:p.Met1=, XP_006715141.1:p.Met1Val, XP_006725103.1:p.Met1=, XP_006725103.1:p.Met1Val, XP_006725762.1:p.Met1=, XP_006725762.1:p.Met1Val, XP_006725880.1:p.Met1=, XP_006725880.1:p.Met1Val, XP_006725971.1:p.Met1=, XP_006725971.1:p.Met1Val, XP_006726061.1:p.Met1=, XP_006726061.1:p.Met1Val, XP_006726151.1:p.Met1=, XP_006726151.1:p.Met1Val, rs113526127, rs114462698, rs11551417, rs117623516, rs17221143, rs3173291, rs77545139
A > G
SNP
M105V
No VIP available CA VA
rs1042713 NC_000005.10:g.148826877G=, NC_000005.10:g.148826877G>A, NC_000005.9:g.148206440G=, NC_000005.9:g.148206440G>A, NG_016421.1:g.5285A=, NG_016421.1:g.5285A>G, NM_000024.5:c.46A=, NM_000024.5:c.46A>G, NP_000015.1:p.Arg16=, NP_000015.1:p.Arg16Gly, XM_005268382.1:c.46G=, XM_005268382.1:c.46G>A, XM_005268383.1:c.46G=, XM_005268383.1:c.46G>A, XP_005268439.1:p.Gly16=, XP_005268439.1:p.Gly16Arg, XP_005268440.1:p.Gly16=, XP_005268440.1:p.Gly16Arg, rs17287432, rs17334179, rs17334242, rs17721693, rs17839749, rs17846639, rs17859732, rs3182174, rs3729940, rs52812686, rs56964295
G > G
SNP
R16G
No VIP available No Clinical Annotations available VA
rs1047626 NC_000004.11:g.42003671A>G, NC_000004.12:g.42001654A>G, NM_006345.3:c.148A>G, NP_006336.3:p.Met50Val, XM_005248044.1:c.148A>G, XM_005248045.1:c.-690A>G, XM_011513620.1:c.148A>G, XP_005248101.1:p.Met50Val, XP_011511922.1:p.Met50Val, rs17412165, rs17530086, rs17845128, rs17856522, rs17857929, rs1801961, rs3187632, rs61370393
A > G
SNP
M50V
No VIP available CA VA
rs10511905 NC_000009.11:g.32348024A>G, NC_000009.12:g.32348026A>G, rs17287836, rs60437187
A > G
SNP
No VIP available CA VA
rs1059288 NC_000006.11:g.33267672A=, NC_000006.11:g.33267672A>G, NC_000006.12:g.33299895A=, NC_000006.12:g.33299895A>G, NG_009876.1:g.19318T=, NG_009876.1:g.19318T>C, NM_001243738.1:c.-1116C>T, NM_001243738.1:c.-1116T>C, NM_003190.4:c.*1865T=, NM_003190.4:c.*1865T>C, NM_004761.4:c.-1067C>T, NM_004761.4:c.-1067T>C, NM_172209.2:c.*1865T=, NM_172209.2:c.*1865T>C, NT_113891.2:g.4711486G=, NT_113891.2:g.4711486G>A, NT_113891.3:g.4711380G=, NT_113891.3:g.4711380G>A, NT_167245.1:g.4548998G=, NT_167245.1:g.4548998G>A, NT_167245.2:g.4543413G=, NT_167245.2:g.4543413G>A, NT_167247.1:g.4741416A=, NT_167247.1:g.4741416A>G, NT_167247.2:g.4735831A=, NT_167247.2:g.4735831A>G, NT_167248.1:g.4499912G=, NT_167248.1:g.4499912G>A, NT_167248.2:g.4494316G=, NT_167248.2:g.4494316G>A, XM_005249256.1:c.-1067C>T, XM_005249256.1:c.-1067T>C, XM_005249257.1:c.-916C>T, XM_005249257.1:c.-916T>C, XM_005249258.1:c.-1116C>T, XM_005249258.1:c.-1116T>C, XM_005272848.1:c.-1067C>T, XM_005272848.1:c.-1067T>C, XM_005272849.1:c.-916C>T, XM_005272849.1:c.-916T>C, XM_005272850.1:c.-1116C>T, XM_005272850.1:c.-1116T>C, XM_005275004.1:c.-1067C>T, XM_005275004.1:c.-1067T>C, XM_005275005.1:c.-916C>T, XM_005275005.1:c.-916T>C, XM_005275006.1:c.-1116C>T, XM_005275006.1:c.-1116T>C, XM_005275273.1:c.-1067C>T, XM_005275273.1:c.-1067T>C, XM_005275274.1:c.-916C>T, XM_005275274.1:c.-916T>C, XM_005275275.1:c.-1116C>T, XM_005275275.1:c.-1116T>C, XM_005275433.1:c.-1067C>T, XM_005275433.1:c.-1067T>C, XM_005275434.1:c.-916C>T, XM_005275434.1:c.-916T>C, XM_005275435.1:c.-1116C>T, XM_005275435.1:c.-1116T>C, XM_011514782.1:c.-606C>T, XM_011514782.1:c.-606T>C, XM_011514784.1:c.-2055C>T, XM_011514784.1:c.-2055T>C, XM_011547265.1:c.-606C>T, XM_011547265.1:c.-606T>C, XM_011547267.1:c.-2055C>T, XM_011547267.1:c.-2055T>C, XM_011547668.1:c.-606C>T, XM_011547668.1:c.-606T>C, XM_011547670.1:c.-2055C>T, XM_011547670.1:c.-2055T>C, XM_011548067.1:c.-606C>T, XM_011548067.1:c.-606T>C, XM_011548069.1:c.-2055C>T, XM_011548069.1:c.-2055T>C, XM_011548256.1:c.-606C>T, XM_011548256.1:c.-606T>C, XM_011548258.1:c.-2055C>T, XM_011548258.1:c.-2055T>C, rs116575952, rs117271736, rs141981667, rs17215259, rs3173276, rs60955773
A > G
SNP
No VIP available CA VA
rs1063320 NC_000006.11:g.29798749C=, NC_000006.11:g.29798749C>G, NC_000006.12:g.29830972C=, NC_000006.12:g.29830972C>G, NG_029039.1:g.8994C=, NG_029039.1:g.8994C>G, NM_002127.5:c.*233C=, NM_002127.5:c.*233C>G, NT_113891.3:g.1314548G=, NT_113891.3:g.1314548G>C, NT_167244.2:g.1096598G=, NT_167244.2:g.1096598G>C, NT_167245.1:g.1099370C=, NT_167245.1:g.1099370C>G, NT_167245.2:g.1093785C=, NT_167245.2:g.1093785C>G, NT_167246.1:g.1099078C=, NT_167246.1:g.1099078C>G, NT_167246.2:g.1093458C=, NT_167246.2:g.1093458C>G, NT_167247.1:g.1099028C=, NT_167247.1:g.1099028C>G, NT_167247.2:g.1093443C=, NT_167247.2:g.1093443C>G, NT_167248.2:g.1093752G=, NT_167248.2:g.1093752G>C, NT_167249.2:g.1137017G=, NT_167249.2:g.1137017G>C, XM_005249055.1:c.*233C=, XM_005249055.1:c.*233C>G, XM_005249056.1:c.*233C>G, XM_005249056.1:c.*233G>C, XM_005249057.1:c.*448C>G, XM_005249057.1:c.*448G>C, XM_005249058.1:c.*233C=, XM_005249058.1:c.*233C>G, XM_005272810.1:c.*247G=, XM_005272810.1:c.*247G>C, XM_005274964.1:c.*233C=, XM_005274964.1:c.*233C>G, XM_005274965.1:c.*233C=, XM_005274965.1:c.*233C>G, XM_005274966.1:c.*448C>G, XM_005274966.1:c.*448G>C, XM_005274967.1:c.*233C=, XM_005274967.1:c.*233C>G, XM_005275119.1:c.*233C=, XM_005275119.1:c.*233C>G, XM_005275120.1:c.*233C>G, XM_005275120.1:c.*233G>C, XM_005275121.1:c.*448C>G, XM_005275121.1:c.*448G>C, XM_005275122.1:c.*233C>G, XM_005275122.1:c.*233G>C, XM_005275246.1:c.*233C=, XM_005275246.1:c.*233C>G, XM_005275247.1:c.*233C=, XM_005275247.1:c.*233C>G, XM_005275248.1:c.*448C>G, XM_005275248.1:c.*448G>C, XM_005275249.1:c.*233C=, XM_005275249.1:c.*233C>G, XM_005275394.1:c.*247G=, XM_005275394.1:c.*247G>C, XM_005275549.1:c.*247G=, XM_005275549.1:c.*247G>C, XM_005275550.1:c.*247C>G, XM_005275550.1:c.*247G>C, XM_005275551.1:c.*462C>G, XM_005275551.1:c.*462G>C, XM_005275552.1:c.*247G=, XM_005275552.1:c.*247G>C, XM_011547651.1:c.*233C=, XM_011547651.1:c.*233C>G, XM_011547882.1:c.*233C=, XM_011547882.1:c.*233C>G, XM_011548048.1:c.*233C=, XM_011548048.1:c.*233C>G, XM_011548236.1:c.*247G=, XM_011548236.1:c.*247G>C, XM_011548237.1:c.*247G=, XM_011548237.1:c.*247G>C, XM_011548430.1:c.*247G=, XM_011548430.1:c.*247G>C, XM_011548431.1:c.*247G=, XM_011548431.1:c.*247G>C, XR_241896.1:n.1859C=, XR_241896.1:n.1859C>G, XR_246963.1:n.1793G=, XR_246963.1:n.1793G>C, XR_247353.1:n.1859C=, XR_247353.1:n.1859C>G, XR_247370.1:n.1859C=, XR_247370.1:n.1859C>G, XR_247389.1:n.1859C=, XR_247389.1:n.1859C>G, XR_247402.1:n.1793G=, XR_247402.1:n.1793G>C, XR_247423.1:n.1851G=, XR_247423.1:n.1851G>C, rs115928989, rs117512550, rs1632929, rs16867727, rs17185496, rs3204385, rs386485817, rs58677621, rs9258500
C > C
C > G
SNP
No VIP available CA VA
rs1074373 NC_000007.13:g.30616761A>C, NC_000007.14:g.30577145A>C, NR_038889.1:n.132-435T>G, rs17488568, rs386422387, rs4392797, rs72494349
A > C
SNP
No VIP available CA VA
rs1110470 NC_000016.10:g.27325106G>A, NC_000016.9:g.27336427G>A, NG_012086.1:g.16177G>A, NM_000418.3:c.-151-4960G>A, NM_001257406.1:c.-19+11086G>A, NM_001257407.1:c.-308+11086G>A, NM_001257997.1:c.-494+11086G>A, XM_005255305.1:c.162+11086G>A, XM_005255307.1:c.-296-4960G>A, XM_005255309.1:c.162+11086G>A, XM_011545825.1:c.-19+11289G>A, XM_011545826.1:c.-151-4960G>A, XM_011545827.1:c.-151-4960G>A, XM_011545829.1:c.-296-4960G>A, XM_011545830.1:c.-296-4960G>A, XM_011545831.1:c.-164+11289G>A, XM_011545832.1:c.-164+11086G>A, XR_243278.1:n.181+11086G>A, rs17785010, rs386516972, rs59554165
G > A
SNP
No VIP available CA VA
rs11252394 NC_000010.10:g.4240870G>A, NC_000010.11:g.4198678G>A, rs60363200
G > A
SNP
No VIP available CA VA
rs1126510 NC_000019.10:g.46620526A>G, NC_000019.9:g.47123783A>G, NM_000960.3:c.*754T>C, XM_005259093.2:c.*1595T>C, XM_005259094.1:c.768+2932T>C, XR_243945.1:n.902+2932T>C, XR_243945.2:n.902+2932T>C, XR_430206.2:n.902+2932T>C, XR_935844.1:n.902+2932T>C, rs3170155, rs59535482
A > G
SNP
No VIP available CA VA
rs1131882 NC_000019.10:g.3595925G>A, NC_000019.9:g.3595923G>A, NG_013363.1:g.15909C>T, NM_001060.5:c.795C>T, NM_201636.2:c.795C>T, NP_001051.1:p.Ile265=, NP_963998.2:p.Ile265=, XM_011528214.1:c.795C>T, XP_011526516.1:p.Ile265=, rs11085026, rs1805043
G > A
SNP
I265I
No VIP available No Clinical Annotations available VA
rs115501901 NC_000020.10:g.46282708C>T, NC_000020.11:g.47653964C>T, NG_016810.1:g.157108C>T, NM_001174087.1:c.*547C>T, NM_001174088.1:c.*547C>T, NM_006534.3:c.*547C>T, NM_181659.2:c.*547C>T, XM_005260564.1:c.*547C>T, XM_005260565.1:c.*547C>T, XM_005260566.1:c.*547C>T, XM_005260567.1:c.*547C>T
C > T
SNP
No VIP available CA VA
rs11587213 NC_000001.10:g.161184875A>G, NC_000001.11:g.161215085A>G, NG_013352.1:g.20771A>G, NG_029043.1:g.4789A>G, NM_004106.1:c.-237A>G, rs17393255, rs36233991, rs60552753
A > G
SNP
No VIP available No Clinical Annotations available VA
rs116551936 NC_000006.11:g.28619532G>A, NC_000006.12:g.28651755G>A, NT_113891.2:g.141700G>A, NT_113891.3:g.141594G>A, XM_011547184.1:c.-333+58078C>T, XR_926657.1:n.332-1420G>A, XR_952220.1:n.344-1420G>A
G > A
SNP
No VIP available No Clinical Annotations available VA
rs11702779 NC_000021.8:g.36368659G>A, NC_000021.9:g.34996362G>A, NG_011402.2:g.993350C>T, NM_001754.4:c.58+52480C>T, XM_005261067.1:c.58+52480C>T, XM_005261069.1:c.58+52480C>T, XM_005261069.3:c.58+52480C>T, XM_005261070.1:c.-46+52480C>T, XM_011529766.1:c.58+52480C>T, XM_011529767.1:c.58+52480C>T, XM_011529768.1:c.58+52480C>T, XM_011529770.1:c.58+52480C>T, XR_937576.1:n.237+52480C>T, rs58072381
G > A
SNP
No VIP available CA VA
rs11819745 NC_000010.10:g.37790412G>A, NC_000010.11:g.37501484G>A
G > A
SNP
No VIP available CA VA
rs119774 NC_000016.10:g.15992976C>T, NC_000016.9:g.16086833C>T, NG_028268.1:g.48400C>T, NM_004996.3:c.49-14840C>T, NT_187607.1:g.1650953C>T, XM_005255326.1:c.49-14840C>T, XM_005255327.1:c.49-14840C>T, XM_005255328.1:c.49-14840C>T, XM_005255329.1:c.49-14840C>T, XM_011522498.1:c.102+724C>T, rs17579308, rs215071
C > T
SNP
No VIP available CA VA
rs12422149 NC_000011.10:g.75172532G>A, NC_000011.9:g.74883577G>A, NG_027921.1:g.26546G>A, NM_001145211.2:c.869G>A, NM_001145212.2:c.503G>A, NM_007256.4:c.935G>A, NP_001138683.1:p.Arg290Gln, NP_001138684.1:p.Arg168Gln, NP_009187.1:p.Arg312Gln, XM_005273732.1:c.587G>A, XP_005273789.1:p.Arg196Gln, rs56415681, rs59614522
G > A
SNP
R290Q
No VIP available CA VA
rs1353411 NC_000014.8:g.52781101G>A, NC_000014.9:g.52314383G>A, NG_013082.1:g.5086G>A, NM_000956.3:c.-166G>A
G > A
SNP
No VIP available CA VA
rs1364805 NC_000004.11:g.107673848T>G, NC_000004.12:g.106752691T>G, XR_939051.1:n.362-36545T>G, XR_939052.1:n.362-36545T>G, XR_939054.1:n.360-36545T>G, rs57093856
T > G
SNP
No VIP available CA VA
rs138335 NC_000022.10:g.41227086C>G, NC_000022.11:g.40831082C>G, NM_001278589.1:c.652-126G>C, NM_003932.4:c.682-126G>C, rs56867976
C > G
SNP
No VIP available CA VA
rs138337 NC_000022.10:g.41231053A>G, NC_000022.11:g.40835049A>G, NM_001278589.1:c.548+511T>C, NM_003932.4:c.578+511T>C, rs17346097
A > G
SNP
No VIP available CA VA
rs1419555 NC_000007.13:g.125569441C>T, NC_000007.14:g.125929387C>T, rs10353417, rs16871550, rs61551269
C > T
SNP
No VIP available CA VA
rs1423515 NC_000005.10:g.82766725G>A, NC_000005.9:g.82062544G>A, rs57137423
G > A
SNP
No VIP available No Clinical Annotations available VA
rs144315541 NC_000016.10:g.4141521G>A, NC_000016.9:g.4191522G>A
G > A
SNP
No VIP available CA VA
rs1522113 NC_000004.11:g.56331771G>A, NC_000004.12:g.55465604G>A, NM_001267843.1:c.439-1799C>T, NM_004898.3:c.439-1799C>T, XM_005265787.1:c.439-1799C>T, XM_006714054.2:c.439-1799C>T, XM_011534409.1:c.439-1799C>T, XM_011534410.1:c.439-1799C>T, XM_011534411.1:c.439-1799C>T, rs61462227
G > A
SNP
No VIP available CA VA
rs1540339 NC_000012.11:g.48257326C>T, NC_000012.12:g.47863543C>T, NG_008731.1:g.46489G>A, NM_000376.2:c.277+1504G>A, NM_001017535.1:c.277+1504G>A, NM_001017536.1:c.427+1504G>A, XM_006719587.2:c.277+1504G>A, XM_011538720.1:c.277+1504G>A, rs386536515, rs60763867
C > T
SNP
No VIP available No Clinical Annotations available VA
rs1544410 NC_000012.11:g.48239835C>T, NC_000012.12:g.47846052C>T, NG_008731.1:g.63980G>A, NM_000376.2:c.1024+283G>A, NM_001017535.1:c.1024+283G>A, NM_001017536.1:c.1174+283G>A, XM_006719587.2:c.1024+283G>A, XM_011538720.1:c.1024+283G>A, XR_944903.1:n.-763C>T, rs386536760, rs56495123, rs56911380
C > T
SNP
No VIP available CA VA
rs1663330 NC_000014.8:g.66443496A>G, NC_000014.9:g.65976778A>G, rs61624486
A > G
SNP
No VIP available CA VA
rs1663332 NC_000014.8:g.66444344C>T, NC_000014.9:g.65977626C>T, rs57877939
C > T
SNP
No VIP available CA VA
rs16851030 NC_000001.10:g.203135452C>T, NC_000001.11:g.203166324C>T, NM_000674.2:c.*424C>T, NM_001048230.1:c.*424C>T, XM_005244899.1:c.*424C>T, XM_005244900.1:c.*424C>T, XM_005244901.1:c.*424C>T, XM_005244902.1:c.*424C>T, XM_005244902.3:c.*424C>T, XM_005244903.1:c.*424C>T, XM_011509203.1:c.*424C>T, XM_011509204.1:c.*424C>T, rs58133030
C > T
SNP
No VIP available CA VA
rs1741981 NC_000001.10:g.32756439T>C, NC_000001.11:g.32290838T>C, NM_004964.2:c.-1332T>C, XM_005270791.1:c.-1638T>C, rs36212120
T > C
SNP
No VIP available CA VA
rs17495520 NC_000005.10:g.167212900C>T, NC_000005.9:g.166639905C>T, XM_005265950.1:c.-74-71864C>T, XM_006714897.1:c.-74-71864C>T, XM_011534604.1:c.-74-71864C>T, rs59210228
C > T
SNP
No VIP available CA VA
rs17701271 NC_000004.11:g.142711243C>A, NC_000004.12:g.141790090C>A, rs60998133
C > A
SNP
No VIP available CA VA
rs1786929 NC_000010.10:g.67679048A>G, NC_000010.11:g.65919290A>G, NG_034072.1:g.1781902T>C, NM_001127384.2:c.*1040T>C, NM_013266.3:c.*1040T>C, XM_005269717.1:c.*1040T>C, XM_005269717.2:c.*1040T>C, rs60427548
A > G
SNP
No VIP available CA VA
rs1805010 NC_000016.10:g.27344882A>G, NC_000016.9:g.27356203A>G, NG_012086.1:g.35953A>G, NM_000418.3:c.223A>G, NM_001257406.1:c.223A>G, NM_001257407.1:c.178A>G, NM_001257997.1:c.-253A>G, NP_000409.1:p.Ile75Val, NP_001244335.1:p.Ile75Val, NP_001244336.1:p.Ile60Val, XM_005255305.1:c.403A>G, XM_005255306.1:c.298A>G, XM_005255307.1:c.78A>G, XM_005255309.1:c.403A>G, XM_011545825.1:c.223A>G, XM_011545826.1:c.223A>G, XM_011545827.1:c.223A>G, XM_011545828.1:c.-45A>G, XM_011545829.1:c.78A>G, XM_011545830.1:c.78A>G, XM_011545831.1:c.78A>G, XM_011545832.1:c.78A>G, XM_011545833.1:c.78A>G, XM_011545834.1:c.-49A>G, XP_005255362.1:p.Ile135Val, XP_005255363.1:p.Ile100Val, XP_005255364.1:p.Val26=, XP_005255366.1:p.Ile135Val, XP_011544127.1:p.Ile75Val, XP_011544128.1:p.Ile75Val, XP_011544129.1:p.Ile75Val, XP_011544131.1:p.Val26=, XP_011544132.1:p.Val26=, XP_011544133.1:p.Val26=, XP_011544134.1:p.Val26=, XP_011544135.1:p.Val26=, XR_243278.1:n.422A>G, rs117802100, rs17513665, rs3024558, rs3116576
A > G
SNP
I75V
No VIP available CA VA
rs1876828 NC_000017.10:g.43911525C=, NC_000017.10:g.43911525C>T, NC_000017.11:g.45834159C=, NC_000017.11:g.45834159C>T, NG_009902.1:g.54898C=, NG_009902.1:g.54898C>T, NM_001145146.1:c.1194+111C>T, NM_001145146.1:c.1194+111T>C, NM_001145147.1:c.987+111C>T, NM_001145147.1:c.987+111T>C, NM_001145148.1:c.1065+310C>T, NM_001145148.1:c.1065+310T>C, NM_001256299.2:c.582+111C>T, NM_001256299.2:c.582+111T>C, NM_001303016.1:c.668+111C>T, NM_001303016.1:c.668+111T>C, NM_001303018.1:c.582+111C>T, NM_001303018.1:c.582+111T>C, NM_001303020.1:c.804+111C>T, NM_001303020.1:c.804+111T>C, NM_004382.4:c.1107+111C>T, NM_004382.4:c.1107+111T>C, NT_167251.1:g.955985A=, NT_167251.1:g.955985A>G, NT_167251.2:g.953992A=, NT_167251.2:g.953992A>G, NT_187663.1:g.536281C=, NT_187663.1:g.536281C>T, XM_005257060.1:c.804+111C>T, XM_005257060.1:c.804+111T>C, rs117816723
C > T
SNP
No VIP available No Clinical Annotations available VA
rs1876829 NC_000017.10:g.43911443T=, NC_000017.10:g.43911443T>C, NC_000017.11:g.45834077T=, NC_000017.11:g.45834077T>C, NG_009902.1:g.54816T=, NG_009902.1:g.54816T>C, NM_001145146.1:c.1194+29C>T, NM_001145146.1:c.1194+29T>C, NM_001145147.1:c.987+29C>T, NM_001145147.1:c.987+29T>C, NM_001145148.1:c.1065+228C>T, NM_001145148.1:c.1065+228T>C, NM_001256299.2:c.582+29C>T, NM_001256299.2:c.582+29T>C, NM_001303016.1:c.668+29C>T, NM_001303016.1:c.668+29T>C, NM_001303018.1:c.582+29C>T, NM_001303018.1:c.582+29T>C, NM_001303020.1:c.804+29C>T, NM_001303020.1:c.804+29T>C, NM_004382.4:c.1107+29C>T, NM_004382.4:c.1107+29T>C, NT_167251.1:g.956067G=, NT_167251.1:g.956067G>A, NT_167251.2:g.954074G=, NT_167251.2:g.954074G>A, NT_187663.1:g.536199T=, NT_187663.1:g.536199T>C, XM_005257060.1:c.804+29C>T, XM_005257060.1:c.804+29T>C, rs111742786, rs141687854
T > C
SNP
No VIP available No Clinical Annotations available VA
rs1876831 NC_000017.10:g.43907745C=, NC_000017.10:g.43907745C>T, NC_000017.11:g.45830379C=, NC_000017.11:g.45830379C>T, NG_009902.1:g.51118C=, NG_009902.1:g.51118C>T, NM_001145146.1:c.643-38C>T, NM_001145146.1:c.643-38T>C, NM_001145147.1:c.436-38C>T, NM_001145147.1:c.436-38T>C, NM_001145148.1:c.556-38C>T, NM_001145148.1:c.556-38T>C, NM_001256299.2:c.31-38C>T, NM_001256299.2:c.31-38T>C, NM_001303016.1:c.253-38C>T, NM_001303016.1:c.253-38T>C, NM_001303018.1:c.31-38C>T, NM_001303018.1:c.31-38T>C, NM_001303020.1:c.253-38C>T, NM_001303020.1:c.253-38T>C, NM_004382.4:c.556-38C>T, NM_004382.4:c.556-38T>C, NT_167251.1:g.959796A=, NT_167251.1:g.959796A>G, NT_167251.2:g.957803A=, NT_167251.2:g.957803A>G, NT_187663.1:g.532501C=, NT_187663.1:g.532501C>T, XM_005257060.1:c.253-38C>T, XM_005257060.1:c.253-38T>C, XR_934792.1:n.-1108A>G, XR_934792.1:n.-1108G>A, XR_951547.1:n.-1114A>G, XR_951547.1:n.-1114G>A, XR_952503.1:n.-1108A>G, XR_952503.1:n.-1108G>A, rs118038278
C > T
SNP
No VIP available No Clinical Annotations available VA
rs2031920 NC_000010.10:g.135339845C>T, NC_000010.11:g.133526341C>T, NG_008383.1:g.3979C>T, NM_000773.3:c.-1055C>T, XM_005252665.1:c.-512C>T, rs3813868
C > T
SNP
No VIP available No Clinical Annotations available VA
rs2069514 NC_000015.10:g.74745879G>A, NC_000015.9:g.75038220G>A, NG_008431.1:g.28338G>A
G > A
SNP
No VIP available CA VA
rs2071888 NC_000006.11:g.33272855G=, NC_000006.11:g.33272855G>C, NC_000006.12:g.33305078G=, NC_000006.12:g.33305078G>C, NG_009876.1:g.14135C=, NG_009876.1:g.14135C>G, NM_003190.4:c.779C=, NM_003190.4:c.779C>G, NM_172208.2:c.779C=, NM_172208.2:c.779C>G, NM_172209.2:c.518C=, NM_172209.2:c.518C>G, NP_003181.3:p.Thr260=, NP_003181.3:p.Thr260Arg, NP_757345.2:p.Thr260=, NP_757345.2:p.Thr260Arg, NP_757346.2:p.Thr173=, NP_757346.2:p.Thr173Arg, NT_113891.2:g.4716678C=, NT_113891.2:g.4716678C>G, NT_113891.3:g.4716572C=, NT_113891.3:g.4716572C>G, NT_167245.1:g.4554190C=, NT_167245.1:g.4554190C>G, NT_167245.2:g.4548605C=, NT_167245.2:g.4548605C>G, NT_167247.1:g.4746599G=, NT_167247.1:g.4746599G>C, NT_167247.2:g.4741014G=, NT_167247.2:g.4741014G>C, NT_167248.1:g.4505105C=, NT_167248.1:g.4505105C>G, NT_167248.2:g.4499509C=, NT_167248.2:g.4499509C>G, XM_005249333.1:c.518C=, XM_005249333.1:c.518C>G, XM_005272864.1:c.518G=, XM_005272864.1:c.518G>C, XM_005275017.1:c.518G=, XM_005275017.1:c.518G>C, XM_005275286.1:c.518C=, XM_005275286.1:c.518C>G, XM_005275448.1:c.518G=, XM_005275448.1:c.518G>C, XM_011514828.1:c.779C=, XM_011514828.1:c.779C>G, XM_011547276.1:c.779G=, XM_011547276.1:c.779G>C, XM_011547679.1:c.779G=, XM_011547679.1:c.779G>C, XM_011548077.1:c.779C=, XM_011548077.1:c.779C>G, XM_011548266.1:c.779G=, XM_011548266.1:c.779G>C, XP_005249390.1:p.Thr173=, XP_005249390.1:p.Thr173Arg, XP_005272921.1:p.Arg173=, XP_005272921.1:p.Arg173Thr, XP_005275074.1:p.Arg173=, XP_005275074.1:p.Arg173Thr, XP_005275343.1:p.Thr173=, XP_005275343.1:p.Thr173Arg, XP_005275505.1:p.Arg173=, XP_005275505.1:p.Arg173Thr, XP_011513130.1:p.Thr260=, XP_011513130.1:p.Thr260Arg, XP_011545578.1:p.Arg260=, XP_011545578.1:p.Arg260Thr, XP_011545981.1:p.Arg260=, XP_011545981.1:p.Arg260Thr, XP_011546379.1:p.Thr260=, XP_011546379.1:p.Thr260Arg, XP_011546568.1:p.Arg260=, XP_011546568.1:p.Arg260Thr, rs116056022, rs117168590, rs141997300, rs17221681, rs3208347, rs52823576, rs56901798
G > C
SNP
T260R
No VIP available CA VA
rs2075797 NC_000014.8:g.52780651C>G, NC_000014.9:g.52313933C>G, NG_013082.1:g.4636C>G, NM_000956.3:c.-616C>G
C > G
SNP
No VIP available CA VA
rs2115819 NC_000010.10:g.45901089A>G, NC_000010.11:g.45405641A>G, NG_011437.1:g.36461A>G, NM_000698.3:c.432-6550A>G, NM_001256153.1:c.432-6550A>G, NM_001256154.1:c.432-6550A>G, NW_003315935.1:g.246472A>G, XM_005271810.1:c.432-6550A>G, XM_005276864.1:c.432-6550A>G, XM_011539564.1:c.432-6550A>G, XM_011546981.1:c.432-6550A>G, rs17444175, rs52816243, rs60572695
A > G
SNP
No VIP available CA VA
rs2228079 NC_000001.10:g.203098275T>G, NC_000001.11:g.203129147T>G, NM_000674.2:c.306T>G, NM_001048230.1:c.306T>G, NP_000665.1:p.Ala102=, NP_001041695.1:p.Ala102=, XM_005244899.1:c.405T>G, XM_005244900.1:c.306T>G, XM_005244901.1:c.-104T>G, XM_005244902.1:c.-179T>G, XM_005244902.3:c.-179T>G, XM_005244903.1:c.-190T>G, XM_011509203.1:c.-190T>G, XM_011509204.1:c.-118T>G, XP_005244956.1:p.Ala135=, XP_005244957.1:p.Ala102=, rs10920568, rs17510614, rs2275350, rs57301282
T > G
SNP
A102A
No VIP available CA VA
rs2239179 NC_000012.11:g.48257766T>C, NC_000012.12:g.47863983T>C, NG_008731.1:g.46049A>G, NM_000376.2:c.277+1064A>G, NM_001017535.1:c.277+1064A>G, NM_001017536.1:c.427+1064A>G, XM_006719587.2:c.277+1064A>G, XM_011538720.1:c.277+1064A>G, rs386562166, rs58094619
T > C
SNP
No VIP available No Clinical Annotations available VA
rs2239185 NC_000012.11:g.48244559G>A, NC_000012.12:g.47850776G>A, NG_008731.1:g.59256C>T, NM_000376.2:c.756-3968C>T, NM_001017535.1:c.756-3968C>T, NM_001017536.1:c.906-3968C>T, XM_006719587.2:c.756-3968C>T, XM_011538720.1:c.756-3968C>T, XR_944903.1:n.329-1369G>A, rs17721547, rs386562169, rs57490981
G > A
SNP
No VIP available CA VA
rs2239347 NC_000016.10:g.27347700A>C, NC_000016.9:g.27359021A>C, NG_012086.1:g.38771A>C, NM_000418.3:c.513+1082A>C, NM_001257406.1:c.513+1082A>C, NM_001257407.1:c.468+1082A>C, NM_001257997.1:c.38+1082A>C, XM_005255305.1:c.693+1082A>C, XM_005255306.1:c.588+1082A>C, XM_005255307.1:c.216+2680A>C, XM_005255309.1:c.693+1082A>C, XM_011545825.1:c.513+1082A>C, XM_011545826.1:c.513+1082A>C, XM_011545827.1:c.513+1082A>C, XM_011545828.1:c.246+1082A>C, XM_011545829.1:c.216+2680A>C, XM_011545830.1:c.216+2680A>C, XM_011545831.1:c.216+2680A>C, XM_011545832.1:c.216+2680A>C, XM_011545833.1:c.216+2680A>C, XM_011545834.1:c.90+2680A>C, XR_243278.1:n.712+1082A>C
A > C
SNP
No VIP available CA VA
rs2240017 NC_000017.10:g.45810919C>G, NC_000017.11:g.47733553C>G, NG_012166.1:g.5310C>G, NM_013351.1:c.99C>G, NP_037483.1:p.His33Gln, XM_011524698.1:c.99C>G, XP_011523000.1:p.His33Gln
C > G
SNP
H33Q
No VIP available CA VA
rs2243250 NC_000005.10:g.132673462C>T, NC_000005.9:g.132009154C>T, NG_023252.1:g.4782C>T, NM_000589.3:c.-589C>T, NM_172348.2:c.-589C>T, rs57341116
C > T
SNP
No VIP available CA VA
rs2267715 NC_000007.13:g.30716087G>A, NC_000007.14:g.30676471G>A, NG_029169.1:g.28633C>T, NM_001202475.1:c.310+5444C>T, NM_001202481.1:c.187+5444C>T, NM_001202482.1:c.229+5444C>T, NM_001202483.1:c.229+5444C>T, NM_001883.4:c.229+5444C>T, XM_011515127.1:c.229+5444C>T, XM_011515128.1:c.229+5444C>T, XM_011515129.1:c.229+5444C>T, XR_242065.1:n.474+5444C>T, rs57512960
G > A
SNP
No VIP available CA VA
rs2284220 NC_000007.13:g.30718103G>A, NC_000007.14:g.30678487G>A, NG_029169.1:g.26617C>T, NM_001202475.1:c.310+3428C>T, NM_001202481.1:c.187+3428C>T, NM_001202482.1:c.229+3428C>T, NM_001202483.1:c.229+3428C>T, NM_001883.4:c.229+3428C>T, XM_011515127.1:c.229+3428C>T, XM_011515128.1:c.229+3428C>T, XM_011515129.1:c.229+3428C>T, XR_242065.1:n.474+3428C>T, rs59857794
G > A
SNP
No VIP available CA VA
rs2305089 NC_000006.11:g.166579270C>T, NC_000006.12:g.166165782C>T, NG_012135.1:g.7862G>A, NM_001270484.1:c.530G>A, NM_003181.3:c.530G>A, NP_001257413.1:p.Gly177Asp, NP_003172.1:p.Gly177Asp, XM_011536080.1:c.530G>A, XM_011536081.1:c.530G>A, XP_011534382.1:p.Gly177Asp, XP_011534383.1:p.Gly177Asp, rs52793205, rs61421018
C > T
SNP
G177D
No VIP available No Clinical Annotations available VA
rs2306168 NC_000011.10:g.75196537C>T, NC_000011.9:g.74907582C>T, NG_027921.1:g.50551C>T, NM_001145211.2:c.1391C>T, NM_001145212.2:c.1025C>T, NM_007256.4:c.1457C>T, NP_001138683.1:p.Ser464Phe, NP_001138684.1:p.Ser342Phe, NP_009187.1:p.Ser486Phe, XM_005273732.1:c.1109C>T, XP_005273789.1:p.Ser370Phe, rs58763761
C > T
SNP
S464F
No VIP available No Clinical Annotations available VA
rs2427827 NC_000001.10:g.159271811T>C, NC_000001.11:g.159302021T>C, NM_002001.3:c.-59-285T>C, XM_005244956.1:c.-50-285T>C, rs60829060
T > C
SNP
No VIP available No Clinical Annotations available VA
rs242939 NC_000017.10:g.43895579C=, NC_000017.10:g.43895579C>T, NC_000017.11:g.45818213C=, NC_000017.11:g.45818213C>T, NG_009902.1:g.38952T=, NG_009902.1:g.38952T>C, NM_001145146.1:c.241+1631C>T, NM_001145146.1:c.241+1631T>C, NM_001145147.1:c.122-3142C>T, NM_001145147.1:c.122-3142T>C, NM_001145148.1:c.241+1631C>T, NM_001145148.1:c.241+1631T>C, NM_001256299.2:c.-285+1631C>T, NM_001256299.2:c.-285+1631T>C, NM_001303016.1:c.24+1631C>T, NM_001303016.1:c.24+1631T>C, NM_001303018.1:c.-198-11002C>T, NM_001303018.1:c.-198-11002T>C, NM_001303020.1:c.24+1631C>T, NM_001303020.1:c.24+1631T>C, NM_004382.4:c.241+1631C>T, NM_004382.4:c.241+1631T>C, NT_167251.1:g.971962A=, NT_167251.1:g.971962A>G, NT_167251.2:g.969969A=, NT_167251.2:g.969969A>G, NT_187663.1:g.520335T=, NT_187663.1:g.520335T>C, XM_005257060.1:c.24+1631C>T, XM_005257060.1:c.24+1631T>C, rs111231077, rs138269860, rs386567027, rs56510730, rs60872113
C > T
SNP
No VIP available No Clinical Annotations available VA
rs242941 NC_000017.10:g.43892520A=, NC_000017.10:g.43892520A>C, NC_000017.11:g.45815154A=, NC_000017.11:g.45815154A>C, NG_009902.1:g.35892C=, NG_009902.1:g.35892C>A, NM_001145146.1:c.122-1310A>C, NM_001145146.1:c.122-1310C>A, NM_001145147.1:c.122-6202A>C, NM_001145147.1:c.122-6202C>A, NM_001145148.1:c.122-1310A>C, NM_001145148.1:c.122-1310C>A, NM_001256299.2:c.-404-1309A>C, NM_001256299.2:c.-404-1309C>A, NM_001303016.1:c.-96-1309A>C, NM_001303016.1:c.-96-1309C>A, NM_001303018.1:c.-199+8057A>C, NM_001303018.1:c.-199+8057C>A, NM_001303020.1:c.-96-1310A>C, NM_001303020.1:c.-96-1310C>A, NM_004382.4:c.122-1310A>C, NM_004382.4:c.122-1310C>A, NT_167251.1:g.975003G=, NT_167251.1:g.975003G>T, NT_167251.2:g.973010G=, NT_167251.2:g.973010G>T, NT_187663.1:g.517276C=, NT_187663.1:g.517276C>A, XM_005257060.1:c.-1405A>C, XM_005257060.1:c.-1405C>A, rs115964505, rs117048103, rs143896677, rs57804702
A > C
SNP
No VIP available CA VA
rs255100 NC_000007.13:g.30728908A>T, NC_000007.14:g.30689292A>T, NG_029169.1:g.15812T>A, NM_001202475.1:c.91-8T>A, NM_001202481.1:c.-260-8T>A, rs59753946
A > T
SNP
No VIP available No Clinical Annotations available VA
rs2569190 NC_000005.10:g.140633331A>G, NC_000005.9:g.140012916A>G, NG_023178.1:g.5371T>C, NM_000591.3:c.-260T>C, NM_001040021.2:c.-121-139T>C, NM_001174104.1:c.-221-39T>C, NM_001174105.1:c.-121-139T>C, XM_011537665.1:c.-129-8334A>G, rs17524551, rs59568848
A > G
SNP
No VIP available CA VA
rs2660845 NC_000012.11:g.96438553G>A, NC_000012.12:g.96044775G>A, NM_001256643.1:c.-1400C>T, NM_001256644.1:c.-1400C>T, rs57157252
G > A
SNP
No VIP available CA VA
rs2781659 NC_000006.11:g.131891820A>G, NC_000006.12:g.131570680A>G, NG_007086.2:g.2456A>G, rs3756775
A > G
SNP
No VIP available No Clinical Annotations available VA
rs28364072 NC_000019.10:g.7690399A>G, NC_000019.9:g.7755285A>G, NG_029554.1:g.16748T>C, NM_001207019.2:c.618+7T>C, NM_001220500.1:c.621+7T>C, NM_002002.4:c.621+7T>C, XM_005272462.1:c.621+7T>C, XM_005272462.3:c.621+7T>C, XR_246667.1:n.823+7T>C, XR_246668.1:n.838+7T>C, rs45446794, rs57282274
A > G
SNP
No VIP available No Clinical Annotations available VA
rs2872507 NC_000017.10:g.38040763G>A, NC_000017.11:g.39884510G>A, rs17305854, rs60658931
G > A
SNP
No VIP available No Clinical Annotations available VA
rs295114 NC_000002.11:g.201195602C>T, NC_000002.12:g.200330879C>T, NM_001100422.1:c.-23+1399C>T, NM_001100423.1:c.-23+1399C>T, NM_001100424.1:c.-23+1399C>T, NM_001282735.1:c.-23+1399C>T, NM_001282743.1:c.-142+1399C>T, NM_001282744.1:c.68+1399C>T, NM_015535.2:c.-23+1399C>T, XM_005246454.1:c.137+1399C>T, XM_005246455.1:c.-23+1399C>T, XM_005246456.1:c.-174+1399C>T, XM_005246457.1:c.-166+1399C>T, XM_005246459.1:c.-23+1399C>T, XM_005246460.1:c.-174+1399C>T, XM_011510938.1:c.68+1399C>T, XM_011510939.1:c.-23+1399C>T, rs3769470, rs386577699, rs60607883
C > T
SNP
No VIP available No Clinical Annotations available VA
rs295137 NC_000002.11:g.201150040C>T, NC_000002.12:g.200285317C>T, rs1217352, rs1217433, rs1217459, rs1653293, rs17531353, rs296805, rs386577704, rs60606350
C > T
SNP
No VIP available CA VA
rs3024530 NC_000016.10:g.27339366A>G, NC_000016.9:g.27350687A>G, NG_012086.1:g.30437A>G, NM_000418.3:c.-18-820A>G, NM_001257406.1:c.-18-820A>G, NM_001257407.1:c.-307-820A>G, NM_001257997.1:c.-493-820A>G, XM_005255305.1:c.163-820A>G, XM_005255306.1:c.58-820A>G, XM_005255307.1:c.-163-820A>G, XM_005255309.1:c.163-820A>G, XM_011545825.1:c.-18-820A>G, XM_011545826.1:c.-18-820A>G, XM_011545827.1:c.-18-820A>G, XM_011545829.1:c.-163-820A>G, XM_011545830.1:c.-163-820A>G, XM_011545831.1:c.-163-820A>G, XM_011545832.1:c.-163-820A>G, XM_011545833.1:c.-2023A>G, XR_243278.1:n.182-820A>G, rs3116574, rs56617075, rs60904591, rs74249468
A > G
SNP
No VIP available No Clinical Annotations available VA
rs3097671 NC_000006.11:g.33047612G=, NC_000006.11:g.33047612G>C, NC_000006.12:g.33079835G=, NC_000006.12:g.33079835G>C, NG_000869.2:g.637G=, NG_000869.2:g.637G>C, NG_033241.1:g.5944C=, NG_033241.1:g.5944C>G, NG_033242.1:g.8910G=, NG_033242.1:g.8910G>C, NM_001242524.1:c.-100+845C>G, NM_001242524.1:c.-100+845G>C, NM_001242525.1:c.-24+845C>G, NM_001242525.1:c.-24+845G>C, NM_002121.5:c.101-837C>G, NM_002121.5:c.101-837G>C, NT_113891.2:g.4491791C=, NT_113891.2:g.4491791C>G, NT_113891.3:g.4491685C=, NT_113891.3:g.4491685C>G, NT_167244.1:g.4334419G=, NT_167244.1:g.4334419G>C, NT_167244.2:g.4384503G=, NT_167244.2:g.4384503G>C, NT_167245.1:g.4328951G=, NT_167245.1:g.4328951G>C, NT_167245.2:g.4323366G=, NT_167245.2:g.4323366G>C, NT_167246.1:g.4505158G=, NT_167246.1:g.4505158G>C, NT_167246.2:g.4499538G=, NT_167246.2:g.4499538G>C, NT_167247.1:g.4384473G=, NT_167247.1:g.4384473G>C, NT_167247.2:g.4378888G=, NT_167247.2:g.4378888G>C, NT_167248.1:g.4280069G=, NT_167248.1:g.4280069G>C, NT_167248.2:g.4274473G=, NT_167248.2:g.4274473G>C, NT_167249.1:g.4528116G=, NT_167249.1:g.4528116G>C, NT_167249.2:g.4528818G=, NT_167249.2:g.4528818G>C, XM_006715078.2:c.-912C>G, XM_006715078.2:c.-912G>C, XM_006725040.2:c.-912C>G, XM_006725040.2:c.-912G>C, XM_006725699.2:c.-912C>G, XM_006725699.2:c.-912G>C, XM_006725817.2:c.-912C>G, XM_006725817.2:c.-912G>C, XM_006725908.2:c.-912C>G, XM_006725908.2:c.-912G>C, XM_006725998.2:c.-912C>G, XM_006725998.2:c.-912G>C, XM_006726088.2:c.-912C>G, XM_006726088.2:c.-912G>C, rs116100529, rs118047355, rs3812232
G > C
SNP
No VIP available CA VA
rs3129294 NC_000006.11:g.33084671A=, NC_000006.11:g.33084671A>C, NC_000006.12:g.33116894A=, NC_000006.12:g.33116894A>C, NT_113891.2:g.4528780C=, NT_113891.2:g.4528780C>A, NT_113891.3:g.4528674C=, NT_113891.3:g.4528674C>A, NT_167244.1:g.4371434A=, NT_167244.1:g.4371434A>C, NT_167244.2:g.4421518A=, NT_167244.2:g.4421518A>C, NT_167246.1:g.4542256A=, NT_167246.1:g.4542256A>C, NT_167246.2:g.4536636A=, NT_167246.2:g.4536636A>C, NT_167247.1:g.4421488A=, NT_167247.1:g.4421488A>C, NT_167247.2:g.4415903A=, NT_167247.2:g.4415903A>C, NT_167248.1:g.4317163A=, NT_167248.1:g.4317163A>C, NT_167248.2:g.4311567A=, NT_167248.2:g.4311567A>C, NT_167249.1:g.4565158C=, NT_167249.1:g.4565158C>A, NT_167249.2:g.4565860C=, NT_167249.2:g.4565860C>A, rs111872825, rs115401827, rs117469093
A > C
SNP
No VIP available CA VA
rs3130100 NC_000006.11:g.33283766T=, NC_000006.11:g.33283766T>C, NC_000006.12:g.33315989T=, NC_000006.12:g.33315989T>C, NG_009876.1:g.3224A=, NG_009876.1:g.3224A>G, NM_001145338.1:c.928A=, NM_001145338.1:c.928A>G, NM_003190.4:c.-1948A>G, NM_003190.4:c.-1948G>A, NM_005453.4:c.928A=, NM_005453.4:c.928A>G, NM_172208.2:c.-1948A>G, NM_172208.2:c.-1948G>A, NM_172209.2:c.-1948A>G, NM_172209.2:c.-1948G>A, NP_001138810.1:p.Thr310=, NP_001138810.1:p.Thr310Ala, NP_005444.4:p.Thr310=, NP_005444.4:p.Thr310Ala, NT_113891.2:g.4727578C=, NT_113891.2:g.4727578C>T, NT_113891.3:g.4727472C=, NT_113891.3:g.4727472C>T, NT_167245.1:g.4565089C=, NT_167245.1:g.4565089C>T, NT_167245.2:g.4559504C=, NT_167245.2:g.4559504C>T, NT_167247.1:g.4757508T=, NT_167247.1:g.4757508T>C, NT_167247.2:g.4751923T=, NT_167247.2:g.4751923T>C, NT_167248.1:g.4516012C=, NT_167248.1:g.4516012C>T, NT_167248.2:g.4510416C=, NT_167248.2:g.4510416C>T, XM_005249333.1:c.-1948A>G, XM_005249333.1:c.-1948G>A, XM_005272864.1:c.-1948A>G, XM_005272864.1:c.-1948G>A, XM_005275017.1:c.-1948A>G, XM_005275017.1:c.-1948G>A, XM_005275286.1:c.-1948A>G, XM_005275286.1:c.-1948G>A, XM_005275448.1:c.-1948A>G, XM_005275448.1:c.-1948G>A, XM_011514828.1:c.-1948A>G, XM_011514828.1:c.-1948G>A, XM_011547276.1:c.-1948A>G, XM_011547276.1:c.-1948G>A, XM_011547679.1:c.-1948A>G, XM_011547679.1:c.-1948G>A, XM_011548077.1:c.-1948A>G, XM_011548077.1:c.-1948G>A, XM_011548266.1:c.-1948A>G, XM_011548266.1:c.-1948G>A, rs115558214, rs117619983, rs146168776, rs17856567, rs57230775
T > C
SNP
T310A
No VIP available No Clinical Annotations available VA
rs3213729 NC_000014.8:g.73393246G>C, NC_000014.9:g.72926538G>C, NM_001163508.1:c.-14G>C, NM_001163509.1:c.-48G>C, NM_015604.3:c.-14G>C, NM_181340.2:c.-214G>C, NM_181341.2:c.-14G>C, XM_005267522.1:c.-14G>C, XM_005267522.3:c.-14G>C, XM_005267523.1:c.-400G>C, XM_005267523.3:c.-400G>C, XM_005267525.1:c.-48G>C, XM_005267525.3:c.-48G>C, XM_005267526.1:c.-434G>C, XM_005267526.3:c.-434G>C, XM_005267527.1:c.-214G>C, XM_006720113.2:c.-564G>C, XM_006720114.2:c.-14G>C, XM_006720115.2:c.-598G>C, rs60333922
G > C
SNP
No VIP available CA VA
rs34548976 NC_000007.13:g.31072469C>T, NC_000007.14:g.31032854C>T, rs57244668
C > T
SNP
No VIP available No Clinical Annotations available VA
rs35599367 NC_000007.13:g.99366316G>A, NC_000007.14:g.99768693G>A, NG_008421.1:g.20493C>T, NM_001202855.2:c.522-191C>T, NM_017460.5:c.522-191C>T, XM_011515841.1:c.522-191C>T, XM_011515842.1:c.522-191C>T, rs45581939, rs62471940
G > A
SNP
No VIP available No Clinical Annotations available VA
rs3752120 NC_000019.10:g.52048768C>T, NC_000019.9:g.52552021C>T, NM_014650.2:c.-266G>A, XM_011527548.1:c.-352G>A, rs59249515
C > T
SNP
No VIP available CA VA
rs3775291 NC_000004.11:g.187004074C>T, NC_000004.12:g.186082920C>T, NG_007278.1:g.18766C>T, NM_003265.2:c.1234C>T, NP_003256.1:p.Leu412Phe, rs386586050, rs52805499, rs56463237, rs60096761
C > T
SNP
L412F
No VIP available No Clinical Annotations available VA
rs3782905 NC_000012.11:g.48266167G>C, NC_000012.12:g.47872384G>C, NG_008731.1:g.37648C>G, NM_000376.2:c.146+6584C>G, NM_001017535.1:c.146+6584C>G, NM_001017536.1:c.296+6584C>G, XM_006719587.2:c.146+6584C>G, XM_011538720.1:c.146+6584C>G, rs58878574
G > C
SNP
No VIP available CA VA
rs37973 NC_000007.13:g.8007876G=, NC_000007.13:g.8007876G>A, NC_000007.14:g.7968245G=, NC_000007.14:g.7968245G>A, NG_032073.1:g.4503G=, NG_032073.1:g.4503G>A, NM_138426.3:c.-1106G=, NM_138426.3:c.-1106G>A, NR_110018.1:n.209+299C=, NR_110018.1:n.209+299C>T, XM_005249606.1:c.-1106G=, XM_005249606.1:c.-1106G>A, XM_005249607.1:c.-1106G=, XM_005249607.1:c.-1106G>A, XM_005249608.1:c.-1106G=, XM_005249608.1:c.-1106G>A, XR_927011.1:n.585G=, XR_927011.1:n.585G>A, XR_927012.1:n.991G=, XR_927012.1:n.991G>A, rs10350539, rs58886078
G > A
SNP
No VIP available No Clinical Annotations available VA
rs3813867 NC_000010.10:g.135339605G>C, NC_000010.11:g.133526101G>C, NG_008383.1:g.3739G>C, NM_000773.3:c.-1295G>C, XM_005252665.1:c.-752G>C, rs57822387
G > C
SNP
No VIP available No Clinical Annotations available VA
rs3818822 NC_000001.10:g.111857208G>A, NC_000001.11:g.111314586G>A, NM_001040623.2:c.-14G>A, NM_001258001.1:c.-21G>A, NM_001258002.1:c.-14G>A, NM_001258003.1:c.-21G>A, NM_001258004.1:c.-319G>A, NM_001258005.1:c.-153G>A, NM_021797.3:c.-21G>A, NM_201653.3:c.304G>A, NP_970615.2:p.Gly102Arg, XM_006710577.2:c.-14G>A, rs52810904, rs60274821
G > A
SNP
G102R
No VIP available CA VA
rs3856806 NC_000003.11:g.12475557C>T, NC_000003.12:g.12434058C>T, NG_011749.1:g.151209C>T, NM_005037.5:c.1347C>T, NM_015869.4:c.1431C>T, NM_138711.3:c.1347C>T, NM_138712.3:c.1347C>T, NP_005028.4:p.His449=, NP_056953.2:p.His477=, NP_619725.2:p.His449=, NP_619726.2:p.His449=, XM_011533840.1:c.1347C>T, XM_011533841.1:c.1347C>T, XM_011533842.1:c.1270+16904C>T, XM_011533843.1:c.*143C>T, XM_011533844.1:c.*143C>T, XP_011532142.1:p.His449=, XP_011532143.1:p.His449=, rs17241555, rs56980657
C > T
SNP
H449H
No VIP available No Clinical Annotations available VA
rs3892408 NC_000017.10:g.4541604C>T, NC_000017.11:g.4638309C>T, NM_001140.3:c.715G>A, NP_001131.3:p.Val239Met, XM_005256589.1:c.781G>A, XM_005256590.1:c.598G>A, XP_005256646.1:p.Val261Met, XP_005256647.1:p.Val200Met
C > T
SNP
V239M
No VIP available CA VA
rs4271002 NC_000008.10:g.18248268G>C, NC_000008.11:g.18390758G>C, NG_012246.1:g.4514G>C, NM_000015.2:c.-594G>C, XM_011544358.1:c.-1985G>C, rs17642704
G > C
SNP
No VIP available CA VA
rs4291 NC_000017.10:g.61554194T>A, NC_000017.11:g.63476833T>A, NG_011648.1:g.4761T>A, NM_000789.3:c.-262T>A, XM_005257110.1:c.-717T>A
T > A
SNP
No VIP available CA VA
rs4292 NC_000017.10:g.61554341C>T, NC_000017.11:g.63476980C>T, NG_011648.1:g.4908C>T, NM_000789.3:c.-115C>T, XM_005257110.1:c.-570C>T
C > T
SNP
No VIP available No Clinical Annotations available VA
rs499368 NC_000012.11:g.320920T>A, NC_000012.12:g.211754T>A, NM_001122847.2:c.-58+272A>T, NM_001122848.2:c.-58+272A>T, NM_001206931.1:c.-57-1711A>T, NM_003044.4:c.-422+272A>T, XM_005253744.1:c.-58+272A>T, XM_005253745.1:c.-1607A>T, XM_005253746.1:c.-677A>T, XM_005253747.1:c.-58+272A>T, XM_005253747.3:c.-58+272A>T, XM_005253748.1:c.-58+272A>T, XM_005253748.3:c.-58+272A>T, XM_006719005.2:c.-58+272A>T, XM_011521010.1:c.-58+272A>T, XM_011521011.1:c.-58+272A>T, rs59926658
T > A
T > C
SNP
No VIP available CA VA
rs518350 NC_000022.10:g.27657544C>T, NC_000022.11:g.27261583C>T, rs56642782, rs60893949
C > T
SNP
No VIP available CA VA
rs557881 NC_000012.11:g.319125A>G, NC_000012.12:g.209959A>G, NM_001122847.2:c.28T>C, NM_001122848.2:c.28T>C, NM_001206931.1:c.28T>C, NM_003044.4:c.28T>C, NP_001116319.1:p.Cys10Arg, NP_001116320.1:p.Cys10Arg, NP_001193860.1:p.Cys10Arg, NP_003035.3:p.Cys10Arg, XM_005253744.1:c.28T>C, XM_005253745.1:c.28T>C, XM_005253746.1:c.28T>C, XM_005253747.1:c.28T>C, XM_005253747.3:c.28T>C, XM_005253748.1:c.28T>C, XM_005253748.3:c.28T>C, XM_006719005.2:c.28T>C, XM_011521010.1:c.28T>C, XM_011521011.1:c.28T>C, XP_005253801.1:p.Cys10Arg, XP_005253802.1:p.Cys10Arg, XP_005253803.1:p.Cys10Arg, XP_005253804.1:p.Cys10Arg, XP_005253805.1:p.Cys10Arg, XP_006719068.1:p.Cys10Arg, XP_011519312.1:p.Cys10Arg, XP_011519313.1:p.Cys10Arg, rs117938796, rs60807272
A > G
SNP
C10R
No VIP available No Clinical Annotations available VA
rs5789 NC_000009.11:g.125143973C>A, NC_000009.12:g.122381694C>A, NG_032900.1:g.15745C>A, NM_000962.2:c.709C>A, NM_000962.3:c.709C>A, NM_001271164.1:c.565C>A, NM_001271165.1:c.382C>A, NM_001271166.1:c.382C>A, NM_001271367.1:c.382C>A, NM_001271368.1:c.634C>A, NM_080591.2:c.709C>A, NP_000953.2:p.Leu237Met, NP_001258093.1:p.Leu189Met, NP_001258094.1:p.Leu128Met, NP_001258095.1:p.Leu128Met, NP_001258296.1:p.Leu128Met, NP_001258297.1:p.Leu212Met, NP_542158.1:p.Leu237Met, XM_005252104.1:c.634C>A, XM_005252105.1:c.634C>A, XM_005252105.2:c.634C>A, XM_005252106.1:c.382C>A, XM_011518875.1:c.634C>A, XM_011518876.1:c.382C>A, XP_005252161.1:p.Leu212Met, XP_005252162.1:p.Leu212Met, XP_005252163.1:p.Leu128Met, XP_011517177.1:p.Leu212Met, XP_011517178.1:p.Leu128Met, rs3842796, rs4987007, rs57008519
C > A
SNP
L237M
No VIP available CA VA
rs6002674 NC_000022.10:g.42694220T>C, NC_000022.11:g.42298214T>C, NG_028982.3:g.50403A>G, rs56710721
T > C
SNP
No VIP available No Clinical Annotations available VA
rs6461639 NC_000007.13:g.22186955T>C, NC_000007.14:g.22147337T>C, NM_012294.3:c.1426-318A>G, XM_005249914.1:c.1885-318A>G, XM_005249914.2:c.1885-318A>G, XM_005249915.1:c.1510-318A>G, XM_005249916.1:c.1426-318A>G, XM_005249917.1:c.640-318A>G, XM_011515652.1:c.898-318A>G, rs10362088, rs17765408, rs61523888
T > C
SNP
No VIP available CA VA
rs6475448 NC_000009.11:g.20497142G>A, NC_000009.12:g.20497144G>A, NM_001286691.1:c.185-40358C>T, NM_004529.3:c.194-40358C>T, XM_005251460.1:c.185-40358C>T, rs17752471, rs57055275
G > A
SNP
No VIP available No Clinical Annotations available VA
rs6962027 NC_000007.13:g.136701935T>A, NC_000007.14:g.137017188T>A, NG_011846.2:g.153537T>A, NM_000739.2:c.*922T>A, NM_001006626.1:c.*922T>A, NM_001006627.1:c.*922T>A, NM_001006628.1:c.*922T>A, NM_001006629.1:c.*922T>A, NM_001006630.1:c.*922T>A, NM_001006631.1:c.*922T>A, NM_001006632.1:c.*922T>A, NR_046103.1:n.341+15606A>T, XM_005250130.1:c.*922T>A, XM_011515769.1:c.*922T>A, XM_011515770.1:c.*922T>A, XM_011515771.1:c.*922T>A, rs10385443, rs17500327, rs52835773
T > A
SNP
No VIP available CA VA
rs6962291 NC_000007.13:g.139671117T>A, NC_000007.14:g.139971318T>A, NG_008422.2:g.197937T>A, NM_001061.4:c.1137+9085T>A, NM_001130966.2:c.1137+9085T>A, NM_001166253.1:c.1275+9085T>A, NM_001166254.1:c.933+9085T>A, NM_001314028.1:c.1077+9085T>A, NM_030984.3:c.1137+9085T>A, NR_029394.1:n.1401+9085T>A, XM_011516544.1:c.1137+9085T>A, XR_928042.1:n.926T>A, rs59651288
T > A
SNP
No VIP available CA VA
rs6988229 NC_000008.10:g.139884509C>T, NC_000008.11:g.138872266C>T, NM_152888.2:c.658+5484G>A, XM_005250810.1:c.658+5484G>A, XM_011516883.1:c.658+5484G>A, XM_011516884.1:c.658+5484G>A, XM_011516885.1:c.658+5484G>A, XM_011516886.1:c.571+5484G>A, XM_011516888.1:c.658+5484G>A, XM_011516891.1:c.658+5484G>A, rs60236715
C > T
SNP
No VIP available No Clinical Annotations available VA
rs7142086 NC_000014.8:g.73391593C>T, NC_000014.9:g.72924885C>T, NM_001163508.1:c.-1667C>T, NM_001163509.1:c.-1701C>T, NM_015604.3:c.-1667C>T, NM_181340.2:c.-1867C>T, NM_181341.2:c.-1667C>T, XM_005267522.1:c.-1667C>T, XM_005267522.3:c.-1667C>T, XM_005267523.1:c.-2053C>T, XM_005267523.3:c.-2053C>T, XM_005267525.1:c.-1701C>T, XM_005267525.3:c.-1701C>T, XM_005267526.1:c.-2087C>T, XM_005267526.3:c.-2087C>T, XM_005267527.1:c.-1867C>T, XM_006720113.2:c.-2217C>T, XM_006720114.2:c.-1667C>T, XM_006720115.2:c.-2251C>T, rs60210744
C > T
SNP
No VIP available CA VA
rs7160796 NC_000014.8:g.73394614G>C, NC_000014.9:g.72927906G>C, NM_001163508.1:c.-9+1363G>C, NM_001163509.1:c.-43+1363G>C, NM_015604.3:c.-9+1363G>C, NM_181340.2:c.-209+1363G>C, NM_181341.2:c.-9+1363G>C, XM_005267522.1:c.-9+1363G>C, XM_005267522.3:c.-9+1363G>C, XM_005267523.1:c.-9+977G>C, XM_005267523.3:c.-9+977G>C, XM_005267525.1:c.-43+1363G>C, XM_005267525.3:c.-43+1363G>C, XM_005267526.1:c.-43+977G>C, XM_005267526.3:c.-43+977G>C, XM_005267527.1:c.-209+1363G>C, XM_006720113.2:c.-173+977G>C, XM_006720114.2:c.-9+1363G>C, XM_006720115.2:c.-207+977G>C, XM_011536640.1:c.-1957G>C, rs35949747, rs59450927
G > C
SNP
No VIP available CA VA
rs7179742 NC_000015.10:g.39770852A>G, NC_000015.9:g.40063053A>G, NM_152597.4:c.127-242T>C, XM_005254208.1:c.127-242T>C, XM_005254208.2:c.127-242T>C, XM_005254209.1:c.127-242T>C, XM_005254210.1:c.-442-242T>C, XM_011521305.1:c.127-242T>C, XM_011521306.1:c.127-242T>C, XM_011521307.1:c.127-242T>C, XM_011521308.1:c.127-242T>C, XM_011521309.1:c.127-242T>C, XM_011521310.1:c.127-242T>C, rs57685423
A > G
SNP
No VIP available CA VA
rs730012 NC_000005.10:g.179793637A>C, NC_000005.9:g.179220638A>C, NG_028161.1:g.4653A>C, NM_145867.1:c.-444A>C, XM_005265912.1:c.-288A>C, XM_005265913.1:c.7-237A>C, XM_005265914.1:c.-1757A>C
A > C
SNP
No VIP available No Clinical Annotations available VA
rs731236 NC_000012.11:g.48238757A>G, NC_000012.12:g.47844974A>G, NG_008731.1:g.65058T>C, NM_000376.2:c.1056T>C, NM_001017535.1:c.1056T>C, NM_001017536.1:c.1206T>C, NP_000367.1:p.Ile352=, NP_001017535.1:p.Ile352=, NP_001017536.1:p.Ile402=, XM_006719587.2:c.1056T>C, XM_011538720.1:c.1056T>C, XP_006719650.1:p.Ile352=, XP_011537022.1:p.Ile352=, XR_944903.1:n.-1841A>G, rs118037316, rs17777794, rs17880019, rs2228571, rs386609145, rs59730659
A > G
SNP
I352I
No VIP available No Clinical Annotations available VA
rs73294475 NC_000007.13:g.30701596T>C, NC_000007.14:g.30661980T>C, NG_029169.1:g.43124A>G, NM_001202475.1:c.839+176A>G, NM_001202481.1:c.716+176A>G, NM_001202482.1:c.755+176A>G, NM_001202483.1:c.758+176A>G, NM_001883.4:c.758+176A>G, XM_011515127.1:c.758+176A>G, XM_011515128.1:c.758+176A>G, XM_011515129.1:c.758+176A>G, XR_242065.1:n.1003+176A>G
T > C
SNP
No VIP available No Clinical Annotations available VA
rs739645 NC_000017.10:g.43894990T=, NC_000017.10:g.43894990T>G, NC_000017.11:g.45817624T=, NC_000017.11:g.45817624T>G, NG_009902.1:g.38363T=, NG_009902.1:g.38363T>G, NM_001145146.1:c.241+1042G>T, NM_001145146.1:c.241+1042T>G, NM_001145147.1:c.122-3731G>T, NM_001145147.1:c.122-3731T>G, NM_001145148.1:c.241+1042G>T, NM_001145148.1:c.241+1042T>G, NM_001256299.2:c.-285+1042G>T, NM_001256299.2:c.-285+1042T>G, NM_001303016.1:c.24+1042G>T, NM_001303016.1:c.24+1042T>G, NM_001303018.1:c.-199+10528G>T, NM_001303018.1:c.-199+10528T>G, NM_001303020.1:c.24+1042G>T, NM_001303020.1:c.24+1042T>G, NM_004382.4:c.241+1042G>T, NM_004382.4:c.241+1042T>G, NT_167251.1:g.972552C=, NT_167251.1:g.972552C>A, NT_167251.2:g.970559C=, NT_167251.2:g.970559C>A, NT_187663.1:g.519746T=, NT_187663.1:g.519746T>G, XM_005257060.1:c.24+1042G>T, XM_005257060.1:c.24+1042T>G, rs117808192, rs148938648
T > G
SNP
No VIP available No Clinical Annotations available VA
rs74973995 NC_000011.10:g.97091052A>G, NC_000011.9:g.96962052A>G, rs386492065
A > G
SNP
No VIP available No Clinical Annotations available VA
rs7543182 NC_000001.10:g.71339973C>A, NC_000001.11:g.70874290C>A, NG_029509.1:g.178519G>T, NM_198714.1:c.*24-21431G>T, NM_198716.1:c.1105-21431G>T, NM_198717.1:c.1078-21431G>T, NR_028292.1:n.1336-4971G>T, NR_028293.1:n.1309-4971G>T, NR_028294.1:n.1336-8457G>T, XM_005271051.1:c.1105-8457G>T, XM_005271052.1:c.1105-4971G>T, XM_005271053.1:c.1078-4971G>T, XM_011541809.1:c.1105-8457G>T, XM_011541810.1:c.1170-21431G>T, XM_011541811.1:c.*4-21431G>T, XR_946714.1:n.1342-11893G>T, rs59728317
C > A
SNP
No VIP available CA VA
rs7551789 NC_000001.10:g.71514969A>T, NC_000001.11:g.71049286A>T, NG_029509.1:g.3523T>A, NM_001126044.1:c.-1709T>A, NM_198714.1:c.-1709T>A, NM_198715.2:c.-1709T>A, NM_198716.1:c.-1709T>A, NM_198717.1:c.-1709T>A, NM_198718.1:c.-1709T>A, NM_198719.1:c.-1709T>A, NR_028292.1:n.-1478T>A, NR_028293.1:n.-1478T>A, NR_028294.1:n.-1478T>A, NR_038420.1:n.1259+298A>T, XM_005271051.1:c.-1709T>A, XM_005271052.1:c.-1709T>A, XM_005271053.1:c.-1709T>A, XM_011541809.1:c.-1709T>A, XM_011541810.1:c.-1709T>A, XM_011541811.1:c.-1709T>A, XR_946714.1:n.-1472T>A
A > T
SNP
No VIP available CA VA
rs7572857 NC_000002.11:g.65296798G>A, NC_000002.12:g.65069664G>A, NM_001319100.1:c.220G>A, NM_001319101.1:c.220G>A, NM_015147.2:c.220G>A, NP_001306029.1:p.Gly74Ser, NP_001306030.1:p.Gly74Ser, NP_055962.2:p.Gly74Ser, NR_134966.1:n.434G>A, XM_005264218.1:c.220G>A, XM_005264218.3:c.220G>A, XM_005264219.1:c.220G>A, XM_005264219.2:c.220G>A, XM_005264220.1:c.220G>A, XM_005264221.1:c.220G>A, XM_011532704.1:c.220G>A, XP_005264275.1:p.Gly74Ser, XP_005264276.1:p.Gly74Ser, XP_005264277.1:p.Gly74Ser, XP_005264278.1:p.Gly74Ser, XP_011531006.1:p.Gly74Ser, XR_244927.1:n.423G>A, XR_939674.1:n.423G>A, rs17849706, rs17849872, rs52812658, rs60638735
G > -
G > A
SNP
G74S
No VIP available No Clinical Annotations available VA
rs77149876 NC_000011.10:g.14063584T>C, NC_000011.9:g.14085131T>C, NM_006108.3:c.480-11761T>C, NW_003871075.1:g.121668T>C
T > C
SNP
No VIP available No Clinical Annotations available VA
rs77441273 NC_000014.8:g.92959857G>A, NC_000014.9:g.92493513G>A, NG_023408.1:g.175933G>A, NM_153646.3:c.1754G>A, NM_153647.3:c.1697G>A, NM_153648.3:c.1562G>A, NP_705932.2:p.Arg585Gln, NP_705933.2:p.Arg566Gln, NP_705934.1:p.Arg521Gln, XM_005267341.1:c.1754G>A, XM_011536436.1:c.1895G>A, XM_011536437.1:c.1838G>A, XM_011536438.1:c.*55G>A, XM_011536439.1:c.*55G>A, XM_011536440.1:c.1004G>A, XM_011536441.1:c.836G>A, XM_011536442.1:c.836G>A, XP_005267398.1:p.Arg585Gln, XP_011534738.1:p.Arg632Gln, XP_011534739.1:p.Arg613Gln, XP_011534742.1:p.Arg335Gln, XP_011534743.1:p.Arg279Gln, XP_011534744.1:p.Arg279Gln
G > A
SNP
R585Q
No VIP available CA VA
rs7772821 NC_000006.11:g.132892506T>G, NC_000006.12:g.132571367T>G, NG_016544.1:g.6046T>G, NM_175067.1:c.*8T>G, rs58161682
T > C
T > G
SNP
No VIP available CA VA
rs7793837 NC_000007.13:g.30726777A>T, NC_000007.14:g.30687161A>T, NG_029169.1:g.17943T>A, NM_001202475.1:c.184+2030T>A, NM_001202481.1:c.-166-546T>A, rs10384543, rs58713119
A > T
SNP
No VIP available CA VA
rs7794356 NC_000007.13:g.70738729G>A, NC_000007.14:g.71273743G>A, NM_022479.2:c.239-61807G>A, XM_011516467.1:c.239-61807G>A, XM_011516468.1:c.239-61807G>A, XM_011516469.1:c.239-61807G>A, rs57776492
G > A
SNP
No VIP available No Clinical Annotations available VA
rs77977790 NC_000001.10:g.176695479T>C, NC_000001.11:g.176726343T>C, NG_023390.1:g.268173T>C, NM_020318.2:c.3799-13283T>C, XM_005245422.1:c.3799-13283T>C, XM_005245422.2:c.3799-13283T>C, XM_011509857.1:c.3799-13283T>C, XM_011509858.1:c.3799-13283T>C, XM_011509859.1:c.3799-13283T>C, XR_921907.1:n.4963-13283T>C
T > C
SNP
No VIP available CA VA
rs7862221 NC_000009.11:g.135782221T>C, NC_000009.12:g.132906834T>C, NG_012386.1:g.42800A>G, NM_000368.4:c.1335A>G, NM_001162426.1:c.1332A>G, NM_001162427.1:c.1182A>G, NP_000359.1:p.Glu445=, NP_001155898.1:p.Glu444=, NP_001155899.1:p.Glu394=, XM_005272211.1:c.1335A>G, XM_005272212.1:c.1335A>G, XM_006717271.1:c.1335A>G, XM_006717272.2:c.1335A>G, XM_011518979.1:c.1335A>G, XP_005272268.1:p.Glu445=, XP_005272269.1:p.Glu445=, XP_006717334.1:p.Glu445=, XP_006717335.1:p.Glu445=, XP_011517281.1:p.Glu445=
T > C
SNP
E445E
No VIP available No Clinical Annotations available VA
rs8191725 NC_000006.11:g.160429357A>G, NC_000006.12:g.160008325A>G, NG_011785.3:g.44227A>G, NM_000876.3:c.290-685A>G, NR_047511.1:n.-661T>C, NR_047514.1:n.-661T>C, XR_942419.1:n.305-685A>G
A > G
SNP
No VIP available No Clinical Annotations available VA
rs8191992 NC_000007.13:g.136701308T>A, NC_000007.14:g.137016561T>A, NG_011846.2:g.152910T>A, NM_000739.2:c.*295T>A, NM_001006626.1:c.*295T>A, NM_001006627.1:c.*295T>A, NM_001006628.1:c.*295T>A, NM_001006629.1:c.*295T>A, NM_001006630.1:c.*295T>A, NM_001006631.1:c.*295T>A, NM_001006632.1:c.*295T>A, NR_046103.1:n.341+16233A>T, XM_005250130.1:c.*295T>A, XM_011515769.1:c.*295T>A, XM_011515770.1:c.*295T>A, XM_011515771.1:c.*295T>A, rs10347674, rs17415536, rs61486477
T > A
SNP
No VIP available CA VA
rs881152 NC_000005.10:g.172771552G>A, NC_000005.9:g.172198555G>A, NM_004417.3:c.-600C>T, XM_005265831.1:c.-600C>T, XR_941230.1:n.-1904G>A, XR_941231.1:n.-1904G>A, XR_941232.1:n.144G>A, XR_941233.1:n.144G>A, XR_941236.1:n.-1904G>A, rs35788795
G > A
SNP
No VIP available CA VA
rs8832 NC_000016.10:g.27364466A>G, NC_000016.9:g.27375787A>G, NG_012086.1:g.55537A>G, NM_000418.3:c.*636A>G, NM_001257406.1:c.*636A>G, NM_001257407.1:c.*636A>G, NM_001257997.1:c.*636A>G, XM_005255305.1:c.*636A>G, XM_005255306.1:c.*636A>G, XM_005255307.1:c.*636A>G, XM_005255308.1:c.*636A>G, XM_005255308.2:c.*636A>G, XM_006721043.1:c.*636A>G, XM_011545825.1:c.*636A>G, XM_011545826.1:c.*636A>G, XM_011545827.1:c.*636A>G, XM_011545828.1:c.*636A>G, XM_011545829.1:c.*636A>G, XM_011545830.1:c.*636A>G, XM_011545831.1:c.*636A>G, XM_011545832.1:c.*636A>G, XM_011545833.1:c.*636A>G, XM_011545834.1:c.*636A>G, rs17786231, rs3169482, rs3760093, rs58722874, rs60943009
A > G
SNP
No VIP available No Clinical Annotations available VA
rs892940 NC_000003.11:g.24538838A>G, NC_000003.12:g.24497347A>G, NG_009159.1:g.2476T>C, NR_046244.1:n.406-2185A>G, XR_245154.1:n.1311A>G, rs57381368
A > G
SNP
No VIP available CA VA
rs953977 NC_000013.10:g.40700622G>T, NC_000013.11:g.40126485G>T, XM_011535337.1:c.126-6960C>A, XM_011535338.1:c.54-6960C>A, rs56630385, rs58047607
G > T
SNP
No VIP available CA VA
rs9552679 NC_000013.10:g.23231920T>C, NC_000013.11:g.22657781T>C, rs60874055
T > C
SNP
No VIP available No Clinical Annotations available VA
rs959 NC_000001.10:g.71318261T>C, NC_000001.11:g.70852578T>C, NG_029509.1:g.200231A>G, NM_198714.1:c.*305A>G, NM_198716.1:c.*261A>G, NM_198717.1:c.*261A>G, NR_028292.1:n.1786A>G, NR_028293.1:n.1759A>G, NR_028294.1:n.1855A>G, XM_005271051.1:c.*346A>G, XM_005271052.1:c.*346A>G, XM_005271053.1:c.*346A>G, XM_011541810.1:c.*218A>G, XM_011541811.1:c.*285A>G, XR_426711.2:n.348-2460T>C, XR_426712.2:n.355-378T>C, XR_946714.1:n.1716A>G, XR_947502.1:n.216-2460T>C, rs3198899, rs57473697
T > -
T > C
SNP
No VIP available CA VA
rs967676 NC_000017.10:g.49960309T>C, NC_000017.11:g.51882949T>C, NM_001082533.1:c.279+48041A>G, NM_001082534.1:c.279+48041A>G, NM_020178.4:c.279+48041A>G, rs58910484
T > C
SNP
Alleles, Functions, and Amino Acid Translations are all sourced from dbSNP 147

Overview

Alternate Names: 
Synonym
Airway hyperreactivity; Asthma NOS; Asthma unspecified; Asthma, Bronchial; Asthmas; Asthmas, Bronchial; Asthmatic; BHR - Bronchial hyperreactivity; Bronchial Asthma; Bronchial Asthmas; Bronchial asthma; Bronchial hyperreactivity; Bronchial hyperresponsiveness; Bronchial hypersensitivity; Hyperreactive airways disease
PharmGKB Accession Id: PA443450
External Vocabularies

PharmGKB Curated Pathways

Pathways created internally by PharmGKB based primarily on literature evidence.

  1. Glucocorticoid Pathway - Transcription Regulation, Pharmacodynamics
    Model displaying genes which may be involved in the nuclear complex formed that regulates transcription in response to glucocorticoids.

External Pathways

Links to non-PharmGKB pathways.

PharmGKB contains no links to external pathways for this disease. To report a pathway, click here.

Curated Information ?

EvidenceGene
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
ABCC1
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
ACE
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ADA
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ADAM33
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
ADCY9
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ADH5
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
ADORA1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ADRA1B
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ADRB1
ADRB2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ADRBK1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
AGER
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
AGFG1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
AGT
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
ALOX15
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
ALOX5
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ALOX5AP
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
ARG1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ARG2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
BEST3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
BIRC3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
C7
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
CA10
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CCDC69
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CCL13
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CCL2
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
CD14
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CD28
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CD86
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CD8A
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CEBPD
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
CEP68
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CHI3L1
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
CHIA
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
CHRM2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CLCA1
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
CLOCK
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
COL22A1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
COMT
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CRB1
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
CRHR1
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
CRHR2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CRISPLD2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CRTAM
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CTNNA3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CXCL12
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CXCL8
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CXCR1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CXCR3
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
CYP1A2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CYP24A1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CYP27A1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CYP27B1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CYP2A6
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
CYP2C19
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
CYP2E1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
CYP2J2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CYP2R1
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
CYP3A4
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CYSLTR1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CYSLTR2
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
DCAF4
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
DDC
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
DDIT4
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
DENND1B
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
DPP10
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
DUSP1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
EGR1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
EHF
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ELF5
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ENC1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
EPX
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
F13A1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
FADS2
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
FCER1A
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
FCER1G
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
FCER2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
FKBP4
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
FKBP5
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
FSIP1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
GAB1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
GC
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
GLCCI1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
GNA13
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
GPR126
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
GPR162
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
GRK5
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
GSDMB
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
GSTCD
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
HDAC1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
HDAC2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
HHIP
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
HLA-DPB1
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
HLA-DPB2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
HLA-DQA1
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
HLA-G
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
HNMT
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
HSP90AA1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
HSP90AB1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
HSPA4
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
HTR4
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
IGF2R
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IKBKAP
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IL10
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IL12B
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IL12RB1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IL13
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IL1RL1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IL33
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
IL4
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
IL4R
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IL5
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IL6
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IL6R
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IPO13
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IRAK3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IRF1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ITGB3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ITGB5
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ITPR1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
JAK1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
KCNIP4
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
KLF15
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
KLF9
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
LRIG3
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
LTA4H
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
LTB4R
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
LTB4R2
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
LTC4S
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
MAPK1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
MAPK3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
MAPT
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
MLLT3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
MMP12
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
NAGA
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
NAT2
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
NCOA3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
NCOR2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
NOS3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
NPPA
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
NPSR1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
NR3C1
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
ORMDL3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
P2RX7
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
PAPPA2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PDE11A
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PDE4D
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PER1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PHF11
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PIK3CD
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PLCB1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PNMT
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
POSTN
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
PPARG
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PPM1H
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PPT2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PRKCA
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PRNP
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PTGDR
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
PTGER2
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
PTGER3
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
PTGIR
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
PTGS1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
PTGS2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PYHIN1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
RAP1GAP2
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
RAPGEF5
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
RNASE3
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
RUNX1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
RUNX2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
RUNX3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
SEMA3D
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
SERPINB2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
SERPINE2
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
SH2B3
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
SLC24A4
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
SLC26A4
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
SLC30A9
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
SLC6A12
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
SLCO1B1
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
SLCO2B1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
SNW1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
SOX4
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
SPATS2L
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
SRC
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
SRGAP1
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
ST13
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
STAT1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
STAT3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
STAT6
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
STIP1
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
T
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
TAAR6
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
TAPBP
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
TBX21
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
TBXA2R
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
TBXAS1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
TERC
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
TGFB1
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
THRA
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
THRB
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
THSD4
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
TLR3
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
TMCO6
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
TMEM19
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
TNF
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
TPMT
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
TSC1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
TSC22D3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
TSLP
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
UGT1A1
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
UGT1A3
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
USP38
VDR
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
WBSCR17
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
WDR36
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
WIF1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
WISP1
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
WT1
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
ZBTB22
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
ZNF432
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ZPBP2

Curated Information ?

Relationships from National Drug File - Reference Terminology (NDF-RT)

May Treat
May Prevent
Contraindicated With
No related diseases are available

Publications related to Asthma: 227

No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment. The pharmacogenomics journal. 2016. Park H-W, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
A Phenome-Wide Association Study Identifies a Novel Asthma Risk Locus Near TERC. American journal of respiratory and critical care medicine. 2016. Claar Dru D, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Childhood asthma exacerbations and the Arg16 beta2-receptor polymorphism: A meta-analysis stratified by treatment. The Journal of allergy and clinical immunology. 2016. Turner Steve, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CMTR1 is associated with increased asthma exacerbations in patients taking inhaled corticosteroids. Immunity, inflammation and disease. 2015. Dahlin Amber, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Nuclear Bioavailability of the Glucocorticoid Receptor in a Pediatric Asthma Cohort with Variable Corticosteroid Responsiveness. Pediatric research. 2015. Cornejo Salomon, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Measuring the corticosteroid responsiveness endophenotype in asthmatic patients. The Journal of allergy and clinical immunology. 2015. Clemmer George L, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Stress and Bronchodilator Response in Children with Asthma. American journal of respiratory and critical care medicine. 2015. Brehm John M, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Asthma Pharmacogenomics: 2015 Update. Current allergy and asthma reports. 2015. Davis Joshua S, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Genetic variants in arachidonic acid pathway genes associated with NSAID-exacerbated respiratory disease. Pharmacogenomics. 2015. Ayuso Pedro, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
ST13 polymorphisms and their effect on exacerbations in steroid-treated asthmatic children and young adults. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2015. Vijverberg S J H, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CTNNA3 and SEMA3D: Promising loci for asthma exacerbation identified through multiple genome-wide association studies. The Journal of allergy and clinical immunology. 2015. McGeachie Michael J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Glucocorticoid genes and the developmental origins of asthma susceptibility and treatment response. American journal of respiratory cell and molecular biology. 2015. Sharma Sunita, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association between TAAR6 polymorphisms and airway responsiveness to inhaled corticosteroids in asthmatic patients. Pharmacogenetics and genomics. 2015. Chang Hun Soo, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Vitamin D, the gut microbiome, and the hygiene hypothesis. How does asthma begin?. American journal of respiratory and critical care medicine. 2015. Weiss Scott T, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Pharmacokinetics and pharmacodynamics of an extrafine fixed pMDI combination of beclometasone dipropionate/formoterol fumarate in adolescent asthma. British journal of clinical pharmacology. 2015. Kuna Piotr, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Association of the glucocorticoid receptor D641V variant with steroid-resistant asthma: a case-control study. Pharmacogenetics and genomics. 2015. Zhao Feng, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children. The Journal of allergy and clinical immunology. 2015. Sordillo Joanne E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Vitamin D and the development of allergic disease: how important is it?. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2015. Mirzakhani H, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Ethnic-specific associations of rare and low-frequency DNA sequence variants with asthma. Nature communications. 2015. Igartua Catherine, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma. PloS one. 2015. Dahlin Amber, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Vitamin D Modulates Expression of the Airway Smooth Muscle Transcriptome in Fatal Asthma. PloS one. 2015. Himes Blanca E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Pharmacogenomics in Asthma Therapy: Where Are We and Where Do We Go?. Annual review of pharmacology and toxicology. 2014. Park Heung-Woo, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Exploring the roles of UGT1A1 and UGT1A3 in oral clearance of GSK2190915, a 5-lipoxygenase-activating protein inhibitor. Pharmacogenetics and genomics. 2014. Mosteller Michael, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
A polymorphism in HLA-G modifies statin benefit in asthma. The pharmacogenomics journal. 2014. Naidoo D, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
A genome-wide survey of CD4(+) lymphocyte regulatory genetic variants identifies novel asthma genes. The Journal of allergy and clinical immunology. 2014. Sharma Sunita, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
MicroRNA-10a controls airway smooth muscle cell proliferation via direct targeting of the PI3 kinase pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2014. Hu Ruoxi, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genome-wide interaction studies reveal sex-specific asthma risk alleles. Human molecular genetics. 2014. Myers Rachel A, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
The effects of a Gly16Arg ADRB2 polymorphism on responses to salmeterol or montelukast in Japanese patients with mild persistent asthma. Pharmacogenetics and genomics. 2014. Konno Satoshi, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications. The Journal of allergy and clinical immunology. 2014. Howrylak Judie A, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Asthma: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Annals of the American Thoracic Society. 2014. Jackson Daniel J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
The Vitamin D Antenatal Asthma Reduction Trial (VDAART): Rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in children. Contemporary clinical trials. 2014. Litonjua Augusto A, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Polymorphisms in recent GWA identified asthma genes CA10, SGK493, and CTNNA3 are associated with disease severity and treatment response in childhood asthma. Immunogenetics. 2014. Perin Petra, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Birth cohorts in asthma and allergic diseases: Report of a NIAID/NHLBI/MeDALL joint workshop. The Journal of allergy and clinical immunology. 2014. Bousquet Jean, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
The genomic origins of asthma. Thorax. 2014. Sharma Sunita, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Arg16 ADRB2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting beta2-agonists: results of the pacman cohort. Pharmacogenomics. 2013. Zuurhout Miranda Jl, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Exonic variants associated with development of aspirin exacerbated respiratory diseases. PloS one. 2014. Shin Seung-Woo, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
RNA-Seq Transcriptome Profiling Identifies CRISPLD2 as a Glucocorticoid Responsive Gene that Modulates Cytokine Function in Airway Smooth Muscle Cells. PloS one. 2014. Himes Blanca E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids. The journal of allergy and clinical immunology. In practice. 2014. Wu Ann Chen, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Vitamin D related genes in lung development and asthma pathogenesis. BMC medical genomics. 2013. Kho Alvin T, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Statin use in asthmatics on inhaled corticosteroids is associated with decreased risk of emergency department visits. Current medical research and opinion. 2013. Tse Sze Man, et al. PubMed
No Dosing Guideline available No Drug Label available CA No Variant Annotation available No VIP available No VIP available
Effects of polymorphisms of the SLCO2B1 transporter gene on the pharmacokinetics of montelukast in humans. Journal of clinical pharmacology. 2013. Kim Kyoung-Ah, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Inhaled corticosteroid treatment modulates ZNF432 gene variant's effect on bronchodilator response in asthmatics. The Journal of allergy and clinical immunology. 2013. Wu Ann Chen, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
A polymorphism in the histone deacetylase 1 gene is associated with the response to corticosteroids in asthmatics. The Korean journal of internal medicine. 2013. Kim Min-Hye, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Statin Exposure is Associated with Decreased Asthma-Related Emergency Department Visits and Oral Corticosteroid Use. American journal of respiratory and critical care medicine. 2013. Tse Sze Man, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ITGB5 and AGFG1 variants are associated with severity of airway responsiveness. BMC medical genetics. 2013. Himes Blanca E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
A genome-wide association study of bronchodilator response in Latinos implicates rare variants. The Journal of allergy and clinical immunology. 2013. Drake Katherine A, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association analysis of tapasin polymorphisms with aspirin-exacerbated respiratory disease in asthmatics. Pharmacogenetics and genomics. 2013. Cho Sung-Hwan, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Role of interactions in pharmacogenetic studies: leukotrienes in asthma. Pharmacogenomics. 2013. Via Marc, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16. Pulmonary pharmacology & therapeutics. 2013. Blake Kathryn, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Diagnostic accuracy of the bronchodilator response in children. The Journal of allergy and clinical immunology. 2013. Tse Sze Man, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Association of CYP2C19 Polymorphisms and Lansoprazole-Associated Respiratory Adverse Effects in Children. The Journal of pediatrics. 2013. Lima John J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Polygenic heritability estimates in pharmacogenetics: focus on asthma and related phenotypes. Pharmacogenetics and genomics. 2013. McGeachie Michael J, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
A genome-wide association study of bronchodilator response in asthmatics. The pharmacogenomics journal. 2013. Duan Q L, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Fluticasone Propionate Pharmacogenetics: CYP3A4*22 Polymorphism and Pediatric Asthma Control. The Journal of pediatrics. 2013. Stockmann Chris, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
HLA-DQ strikes again: Genome-wide association study further confirms HLA-DQ in the diagnosis of asthma among adults. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2012. Lasky-Su J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort. Current respiratory care reports. 2012. Chipps Bradley E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Integration of mouse and human genome-wide association data identifies KCNIP4 as an asthma gene. PloS one. 2013. Himes Blanca E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Further replication studies of the EVE Consortium meta-analysis identifies 2 asthma risk loci in European Americans. The Journal of allergy and clinical immunology. 2012. Myers Rachel A, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Tailored second line therapy in asthmatic children with the arginine-16 genotype. Clinical science (London, England : 1979). 2012. Lipworth Brian J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Integrative systems biology approaches in asthma pharmacogenomics. Pharmacogenomics. 2012. Dahlin Amber, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Association among ORMDL3 gene expression, 17q21 polymorphism and response to treatment with inhaled corticosteroids in children with asthma. The pharmacogenomics journal. 2012. Berce V, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor alpha antagonist. The Journal of allergy and clinical immunology. 2012. Slager Rebecca E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. The Journal of allergy and clinical immunology. 2012. Chipps Bradley E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
The Effect of Vitamin D and Inhaled Corticosteroid Treatment on Lung Function in Children. American journal of respiratory and critical care medicine. 2012. Wu Ann Chen, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene. PLoS genetics. 2012. Himes Blanca E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genome-wide association study of the age of onset of childhood asthma. The Journal of allergy and clinical immunology. 2012. Forno Erick, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus. American journal of respiratory and critical care medicine. 2012. Tantisira Kelan G, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genome-wide association analysis of circulating vitamin D levels in children with asthma. Human genetics. 2012. Lasky-Su Jessica, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association between WDR21A polymorphisms and airway responsiveness to inhaled corticosteroids in asthmatic patients. Pharmacogenetics and genomics. 2012. Cho Sung-Hwan, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Very important pharmacogene summary for VDR. Pharmacogenetics and genomics. 2012. Poon Audrey H, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Corticosteroid use and bone mineral accretion in children with asthma: Effect modification by vitamin D. The Journal of allergy and clinical immunology. 2012. Tse Sze Man, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Predicting inhaled corticosteroid response in asthma with two associated SNPs. The pharmacogenomics journal. 2012. McGeachie M J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6. Pharmacogenetics and genomics. 2012. McDonagh Ellen M, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Resequencing candidate genes implicates rare variants in asthma susceptibility. American journal of human genetics. 2012. Torgerson Dara G, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Variation at GLCCI1 and FCER2: one step closer to personalized asthma treatment. Pharmacogenomics. 2012. Maitland-van der Zee Anke Hilse, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
New approaches to personalized medicine for asthma: where are we?. The Journal of allergy and clinical immunology. 2012. Weiss Scott T. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Pharmacogenetics of asthma controller treatment. The pharmacogenomics journal. 2012. Mougey E B, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
A polymorphism in the thyroid hormone receptor gene is associated with bronchodilator response in asthmatics. The pharmacogenomics journal. 2012. Duan Q L, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
FCER2 T2206C variant associated with chronic symptoms and exacerbations in steroid-treated asthmatic children. Allergy. 2011. Koster E S, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association of hypothalamic-pituitary-adrenal axis-related polymorphisms with stress in asthmatic children on inhaled corticosteroids. Neuroimmunomodulation. 2012. Tsartsali Lemonia, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Vitamin D in asthma and allergy: what next?. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology. 2011. Weiss S T, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genome-wide association study reveals class I MHC-restricted T cell-associated molecule gene (CRTAM) variants interact with vitamin D levels to affect asthma exacerbations. The Journal of allergy and clinical immunology. 2011. Du Rose, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
CD14 gene polymorphism is not associated with asthma but rather with bronchial obstruction and hyperreactivity in Slovenian children with non-atopic asthma. Respiratory medicine. 2011. Perin Petra, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genetic and histologic evidence for autophagy in asthma pathogenesis. The Journal of allergy and clinical immunology. 2011. Poon Audrey H, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
The pharmacogenetics and pharmacogenomics of asthma therapy. The pharmacogenomics journal. 2011. Tse S M, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
STAT6 links IL-4/IL-13 stimulation with pendrin expression in asthma and chronic obstructive pulmonary disease. Clinical pharmacology and therapeutics. 2011. Nofziger C, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. The New England journal of medicine. 2011. Tantisira Kelan G, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
RUNX Transcription Factors: Association with Pediatric Asthma and Modulated by Maternal Smoking. American journal of physiology. Lung cellular and molecular physiology. 2011. Haley Kathleen J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nature genetics. 2011. Hirota Tomomitsu, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nature genetics. 2011. Mexico City Childhood Asthma Study (MCAAS), et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genome Wide Association Study to Predict Severe Asthma Exacerbations in Children using Random Forests Classifiers. BMC medical genetics. 2011. Xu Mousheng, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase-delta. The Journal of pharmacology and experimental therapeutics. 2011. Mercado Nicolas, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Role of Toll-like Receptor 3 Variants in Aspirin-Exacerbated Respiratory Disease. Allergy, asthma & immunology research. 2011. Palikhe Nami Shrestha, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Association of SERPINE2 with Asthma. Chest. 2011. Himes Blanca E, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association analysis of thromboxane A synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients. Pharmacogenomics. 2011. Oh Sun-Hee, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Bacterial components plus vitamin D: The ultimate solution to the asthma (autoimmune disease) epidemic?. The Journal of allergy and clinical immunology. 2011. Weiss Scott T. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Influence of gene-gene interactions on response to albuterol therapy. Pharmacogenomics. 2011. Moore Paul E. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity. Pharmacogenetics and genomics. 2010. Kim Byung Soo, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Risk factors and predictive clinical scores for asthma exacerbations in childhood. Chest. 2010. Forno Erick, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
PharmGKB summary: very important pharmacogene information for PTGS2. Pharmacogenetics and genomics. 2010. Thorn Caroline F, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PDE11A associations with asthma: results of a genome-wide association scan. The Journal of allergy and clinical immunology. 2010. DeWan Andrew T, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients. The Journal of allergy and clinical immunology. 2010. Jin Ying, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma. The Journal of allergy and clinical immunology. 2010. Cohen Robyn T, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
PharmGKB summary: cytochrome P450, family 2, subfamily J, polypeptide 2: CYP2J2. Pharmacogenetics and genomics. 2010. Berlin Dorit S, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association of SLC6A12 variants with aspirin-intolerant asthma in a Korean population. Annals of human genetics. 2010. Pasaje Charisse Flerida A, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association analysis of N-acetyl transferase-2 polymorphisms with aspirin intolerance among asthmatics. Pharmacogenomics. 2010. Kim Jin-Moo, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. The Journal of allergy and clinical immunology. 2010. Brehm John M, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
What genes tell us about the pathogenesis of asthma and chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2010. Weiss Scott T. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Association of PTGER gene family polymorphisms with aspirin intolerant asthma in Korean asthmatics. BMB reports. 2010. Park Byung-Lae, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol. Pharmacogenetics and genomics. 2010. Choudhry Shweta, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. American journal of respiratory and critical care medicine. 2010. Bleecker Eugene R, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Pharmacodynamics and pharmacokinetics of AM103, a novel inhibitor of 5-lipoxygenase-activating protein (FLAP). Clinical pharmacology and therapeutics. 2010. Bain G, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Arginase 1 and arginase 2 variations associate with asthma, asthma severity and beta2 agonist and steroid response. Pharmacogenetics and genomics. 2010. Vonk Judith M, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
A role for Wnt signaling genes in the pathogenesis of impaired lung function in asthma. American journal of respiratory and critical care medicine. 2010. Sharma Sunita, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Development of a Pharmacogenetic Predictive Test in asthma: proof of concept. Pharmacogenetics and genomics. 2010. Wu Ann Chen, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
A genome-wide association study on African-ancestry populations for asthma. The Journal of allergy and clinical immunology. 2010. Mathias Rasika A, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Stronger evidence for replication of NPPA using genome-wide genotyping data. American journal of respiratory and critical care medicine. 2010. Rogers Angela J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Very important pharmacogene summary ADRB2. Pharmacogenetics and genomics. 2010. Litonjua Augusto A, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Variants of DENND1B associated with asthma in children. The New England journal of medicine. 2010. Sleiman Patrick M A, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Positive association between aspirin-intolerant asthma and genetic polymorphisms of FSIP1: a case-case study. BMC pulmonary medicine. 2010. Kim Jason Yongha, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma. PloS one. 2010. Kim Jeong-Hyun, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Adrenergic beta(2)-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol. The Journal of allergy and clinical immunology. 2009. Basu Kaninika, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
MMP12, lung function, and COPD in high-risk populations. The New England journal of medicine. 2009. Hunninghake Gary M, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet. 2009. Wechsler Michael E, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association analysis of peroxisome proliferator-activated receptors gamma gene polymorphisms with asprin hypersensitivity in asthmatics. Allergy, asthma & immunology research. 2009. Oh Sun-Hee, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
The HLA allele marker for differentiating ASA hypersensitivity phenotypes. Allergy. 2009. Lee H-Y, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease. American journal of human genetics. 2009. Verlaan Dominique J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Predicting response to short-acting bronchodilator medication using Bayesian networks. Pharmacogenomics. 2009. Himes Blanca E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genetics and pharmacogenetics of the leukotriene pathway. The Journal of allergy and clinical immunology. 2009. Tantisira Kelan G, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Impact of pharmacokinetics and pharmacogenetics on the efficacy of pranlukast in Japanese asthmatics. Respirology (Carlton, Vic.). 2009. Asano Koichiro, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PRKCA: a positional candidate gene for body mass index and asthma. American journal of human genetics. 2009. Murphy Amy, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genetic ancestry modifies pharmacogenetic gene-gene interaction for asthma. Pharmacogenetics and genomics. 2009. Corvol Harriet, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Leukotriene pathway genetics and pharmacogenetics in allergy. Allergy. 2009. Duroudier N P, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Assessing the reproducibility of asthma candidate gene associations, using genome-wide data. American journal of respiratory and critical care medicine. 2009. Rogers Angela J, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response. Allergy. 2009. Park H-W, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. American journal of human genetics. 2009. Himes Blanca E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci. Pharmacogenetics and genomics. 2009. Tantisira Kelan G, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenetics and genomics. 2009. Mougey Edward B, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Asthma pharmacogenetic study using finite mixture models to handle drug-response heterogeneity. Pharmacogenomics. 2009. York Timothy P, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly beta(2)-adrenergic polymorphisms. Current medical research and opinion. 2009. Yancey Steven W, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nature genetics. 2009. Gudbjartsson Daniel F, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma. Respiratory medicine. 2009. Kim Sang-Heon, et al. PubMed
No Dosing Guideline available No Drug Label available CA No Variant Annotation available No VIP available No VIP available
Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD. Respirology (Carlton, Vic.). 2009. Kim Woo J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Pharmacogenetics of asthma. Current opinion in pulmonary medicine. 2009. Lima John J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Asthma and genes encoding components of the vitamin D pathway. Respiratory research. 2009. Bossé Yohan, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Importin-13 genetic variation is associated with improved airway responsiveness in childhood asthma. Respiratory research. 2009. Raby Benjamin A, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2008. Kim T-H, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Effect of 17q21 variants and smoking exposure in early-onset asthma. The New England journal of medicine. 2008. Bouzigon Emmanuelle, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. American journal of respiratory and critical care medicine. 2008. Litonjua Augusto A, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Chromosome 17: association of a large inversion polymorphism with corticosteroid response in asthma. Pharmacogenetics and genomics. 2008. Tantisira Kelan G, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association of three sets of high-affinity IgE receptor (FcepsilonR1) polymorphisms with aspirin-intolerant asthma. Respiratory medicine. 2008. Palikhe Nami Shrestha, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Pharmacogenomics and outcome of asthma: no clinical application for long-term steroid effects by CRHR1 polymorphisms. The Journal of allergy and clinical immunology. 2008. Dijkstra Antoon, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Influence of beta2-adrenoceptor polymorphisms on the response to chronic use of albuterol in asthmatic children. Pediatric pulmonology. 2008. Giubergia Verónica, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Association of IL-13 polymorphisms with leukotriene receptor antagonist drug responsiveness in Korean children with exercise-induced bronchoconstriction. Pharmacogenetics and genomics. 2008. Kang Mi-Jin, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthma. Pharmacogenetics and genomics. 2008. Poon Audrey H, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Pharmacogenetic response to albuterol among asthmatics. Pharmacogenomics. 2008. Corvol Harriet, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. The New England journal of medicine. 2008. Ober Carole, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Clinical consequences of ADRbeta2 polymorphisms. Pharmacogenomics. 2008. Hawkins Gregory A, et al. PubMed
No Dosing Guideline available No Drug Label available CA No Variant Annotation available No VIP available No VIP available
Analysis of high-affinity IgE receptor (FcepsilonR1) polymorphisms in patients with aspirin-intolerant chronic urticaria. Allergy and asthma proceedings : the official journal of regional and state allergy societies. 2008. Palikhe Nami, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Lancet. 2007. Bleecker Eugene R, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. The Journal of allergy and clinical immunology. 2007. Tantisira Kelan G, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Allele-specific targeting of microRNAs to HLA-G and risk of asthma. American journal of human genetics. 2007. Tan Zheng, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Association of IL4R gene polymorphisms with asthma in Chinese populations. Human mutation. 2007. Zhang Haibing, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Patient-reported adverse events under asthma therapy: a community pharmacy-based survey. Clinical pharmacology and therapeutics. 2007. Laforest L, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
A functional CD86 polymorphism associated with asthma and related allergic disorders. Journal of medical genetics. 2007. Corydon Thomas Juhl, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature. 2007. Moffatt Miriam F, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
IRAK-M is involved in the pathogenesis of early-onset persistent asthma. American journal of human genetics. 2007. Balaci Lenuta, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
PPARG locus haplotype variation and exacerbations in asthma. Clinical pharmacology and therapeutics. 2007. Palmer C N A, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients. Pharmacogenomics. 2007. Kim Seung-Hyun, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. Pharmacogenetics and genomics. 2007. Kim Sang-Heon, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Effects of supportive treatment such as antioxidant or leukotriene receptor antagonist drugs on inflammatory and respiratory parameters in asthma patients. Clinical pharmacology and therapeutics. 2007. Tug T, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Pharmacogenetics of the human beta-adrenergic receptors. The pharmacogenomics journal. 2007. Taylor M R G. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol. Thorax. 2006. Palmer C N A, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Associations between CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluric acid/theophylline ratios. European journal of clinical pharmacology. 2006. Yoon Yeomin, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. American journal of respiratory and critical care medicine. 2006. Lima John J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. The Journal of allergy and clinical immunology. 2006. Bleecker Eugene R, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
beta-Adrenergic receptor polymorphisms and response to salmeterol. American journal of respiratory and critical care medicine. 2006. Wechsler Michael E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Pharmacogenomics: catechol O-methyltransferase to thiopurine S-methyltransferase. Cellular and molecular neurobiology. 2006. Weinshilboum Richard M. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Overview of the pharmacogenetics of asthma treatment. The pharmacogenomics journal. 2006. Weiss S T, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
CXCR3 polymorphisms associated with risk of asthma. Biochemical and biophysical research communications. 2005. Cheong Hyun Sub, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2005. Kim S-H, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. The Journal of clinical investigation. 2005. Sun Chun-Xiao, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proceedings of the National Academy of Sciences of the United States of America. 2004. Tantisira Kelan G, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Polymorphisms in signal transducer and activator of transcription 3 and lung function in asthma. Respiratory research. 2005. Litonjua Augusto A, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Association of vitamin D receptor gene polymorphisms with childhood and adult asthma. American journal of respiratory and critical care medicine. 2004. Raby Benjamin A, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. American journal of respiratory and critical care medicine. 2004. Poon Audrey H, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
The IL12B gene is associated with asthma. American journal of human genetics. 2004. Randolph Adrienne G, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Association between a polymorphism in cysteinyl leukotriene receptor 2 on chromosome 13q14 and atopic asthma. Pharmacogenetics. 2004. Fukai Hiromi, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma. Pharmacogenetics. 2004. Pillai Sreekumar G, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Defining a link with asthma in mice congenitally deficient in eosinophils. Science (New York, N.Y.). 2004. Lee James J, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Human molecular genetics. 2004. Tantisira Kelan G, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Induction of early growth-response factor 1 by platelet-derived growth factor in human airway smooth muscle. American journal of physiology. Lung cellular and molecular physiology. 2004. Hjoberg Josephine, et al. PubMed
No Dosing Guideline available No Drug Label available CA No Variant Annotation available No VIP available No VIP available
HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population. The Journal of allergy and clinical immunology. 2004. Choi Jeong Hee, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. American journal of respiratory and critical care medicine. 2004. Silverman Eric S, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. American journal of respiratory and critical care medicine. 2003. Lind Denise L, et al. PubMed
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet. 2004. Israel Elliot, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program. The Journal of allergy and clinical immunology. 2003. Silverman Edwin K, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
An Ile to Met polymorphism in the catalytic domain of adenylyl cyclase type 9 confers reduced beta2-adrenergic receptor stimulation. Pharmacogenetics. 2003. Small Kersten M, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Antithetic regulation by beta-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway beta-agonist paradox. The Journal of clinical investigation. 2003. McGraw Dennis W, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Association of a missense mutation in the NOS3 gene with exhaled nitric oxide levels. American journal of respiratory and critical care medicine. 2003. Storm van's Gravesande Karin, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumour necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2003. Tomari S, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clinical pharmacology and therapeutics. 2003. Obase Yasushi, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Salmeterol (Serevent) asthma trial halted early. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2003. Wooltorton Eric. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Constitutive and cytokine-induced expression of the ETS transcription factor ESE-3 in the lung. American journal of respiratory cell and molecular biology. 2002. Silverman Eric S, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
DNA sequence variants in epithelium-specific ETS-2 and ETS-3 are not associated with asthma. American journal of respiratory and critical care medicine. 2002. Baron Rebecca M, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Sequence variants in the FcepsilonRI alpha chain gene. Journal of applied physiology (Bethesda, Md. : 1985). 2002. Shikanai Toshiki, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Role of the JAK-STAT pathway in PDGF-stimulated proliferation of human airway smooth muscle cells. American journal of physiology. Lung cellular and molecular physiology. 2002. Simon Amy R, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
5-Lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonists. European journal of clinical pharmacology. 2002. Fowler Stephen J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Pharmacogenetics of asthma. American journal of respiratory and critical care medicine. 2002. Palmer Lyle J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Cloning and functional analysis of the mouse 5-lipoxygenase promoter. American journal of respiratory cell and molecular biology. 2002. Silverman Eric S, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Gene expression profiling in inflammatory airway disease associated with elevated adenosine. American journal of physiology. Lung cellular and molecular physiology. 2002. Banerjee Suman K, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Theoretical 3D model of histamine N-methyltransferase: insights into the effects of a genetic polymorphism on enzymatic activity and thermal stability. Biochemical and biophysical research communications. 2001. Pang Y P, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s). European journal of pharmacology. 2001. Green S A, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Association of asthma with beta(2)-adrenergic receptor gene polymorphism and cigarette smoking. American journal of respiratory and critical care medicine. 2001. Wang Z, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma. International archives of allergy and immunology. 2001. Israel E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Airway wall remodelling and hyperresponsiveness: modelling remodelling in vitro and in vivo. Pulmonary pharmacology & therapeutics. 2001. Stewart A G. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Heat shock proteins' mRNA expression in asthma. Respirology (Carlton, Vic.). 2000. Tong W, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism. Thorax. 2000. Taylor D R, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. American journal of respiratory and critical care medicine. 2000. Israel E, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Tolerance to beta-agonists during acute bronchoconstriction. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology. 1999. Hancox R J, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nature genetics. 1999. Drazen J M, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Estrogen acutely stimulates endothelial nitric oxide synthase in H441 human airway epithelial cells. American journal of respiratory cell and molecular biology. 1999. Kirsch E A, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Effects of gender and race on albuterol pharmacokinetics. Pharmacotherapy. 1999. Mohamed M H, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. American journal of respiratory and critical care medicine. 1998. Weir T D, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. The Journal of clinical investigation. 1997. Martinez F D, et al. PubMed
No Dosing Guideline available No Drug Label available CA No Variant Annotation available No VIP available No VIP available
Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 1997. Dekker J W, et al. PubMed
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
Inhibition of interleukin-5 gene expression by dexamethasone. Immunology. 1992. Rolfe F G, et al. PubMed